Claudio Borghi
#114,747
Most Influential Person Now
Italian physician
Claudio Borghi's AcademicInfluence.com Rankings
Claudio Borghiphilosophy Degrees
Philosophy
#4940
World Rank
#7624
Historical Rank
Logic
#2298
World Rank
#3262
Historical Rank
Download Badge
Philosophy
Claudio Borghi's Degrees
- Doctorate Medicine University of Milan
- PhD Medical Sciences University of Milan
Why Is Claudio Borghi Influential?
(Suggest an Edit or Addition)Claudio Borghi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). (2011) (1677)
- 2020 International Society of Hypertension Global Hypertension Practice Guidelines. (2020) (1254)
- 2020 International Society of Hypertension global hypertension practice guidelines. (2020) (794)
- ESC Guidelines on the Management of Cardiovascular Diseases During Pregnancy (2012) (788)
- The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction (1995) (710)
- Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients (2009) (579)
- Serum uric acid and the risk of cardiovascular and renal disease. (2015) (376)
- Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study (2011) (327)
- Age and Multimorbidity Predict Death Among COVID-19 Patients (2020) (294)
- Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation. (2018) (279)
- The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. (1995) (202)
- May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension (2019) (182)
- Is it time to revise the normal range of serum uric acid levels? (2014) (178)
- Predictors of stable hypertension in young borderline subjects: a five-year follow-up study. (1986) (177)
- Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study (2014) (146)
- Evidence of a Partial Escape of Renin‐Angiotensin‐Aldosterone Blockade in Patients with Acute Myocardial Infarction Treated with Ace Inhibitors (1993) (146)
- Relationship of systemic hemodynamics, left ventricular structure and function, and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia. (2000) (146)
- Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia. (2000) (138)
- Dietary linoleic acid and human health: Focus on cardiovascular and cardiometabolic effects. (2019) (137)
- Blood pressure control in Italy: results of recent surveys on hypertension (2007) (133)
- Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials (2011) (130)
- Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years (2019) (112)
- Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study. (2004) (108)
- Survey of physicians’ practices in the control of cardiovascular risk factors: the EURIKA study (2012) (106)
- Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study (2010) (104)
- Do the Lactotripeptides Isoleucine–Proline–Proline and Valine–Proline–Proline Reduce Systolic Blood Pressure in European Subjects? A Meta-Analysis of Randomized Controlled Trials (2013) (102)
- The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD (2019) (101)
- Elevated serum uric acid increases risks for developing high LDL cholesterol and hypertriglyceridemia: A five-year cohort study in Japan. (2018) (98)
- Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study (2006) (97)
- Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease. (2020) (96)
- Continuous ultrafiltration for congestive heart failure: the CUORE trial. (2014) (94)
- May Measurement Month 2019 (2019) (92)
- Nutraceuticals with a clinically detectable blood pressure-lowering effect: a review of available randomized clinical trials and their meta-analyses. (2017) (87)
- Blood pressure control in Italy: analysis of clinical data from 2005–2011 surveys on hypertension (2012) (86)
- Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation. (1999) (84)
- EFFECT OF RESVERATROL ON BLOOD PRESSURE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED, CONTROLLED, CLINICAL TRIALS (2018) (82)
- Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trials. (2020) (80)
- Serum uric acid change and modification of blood pressure and fasting plasma glucose in an overall healthy population sample: data from the Brisighella heart study (2017) (78)
- Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study (2018) (77)
- High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects. (2017) (76)
- Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial (2019) (76)
- Lack of control of hypertension in primary cardiovascular disease prevention in Europe: Results from the EURIKA study. (2016) (76)
- Different Effect of Psyllium and Guar Dietary Supplementation on Blood Pressure Control in Hypertensive Overweight Patients: A Six-Month, Randomized Clinical Trial (2007) (74)
- Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study (2017) (73)
- Omega-3 polyunsaturated fatty acids: Their potential role in blood pressure prevention and management (2006) (72)
- Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study. (2003) (72)
- Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project (2020) (69)
- Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study (2017) (67)
- Effects of Moderate Salt Restriction on Intralymphocytic Sodium and Pressor Response to Stress in Borderline Hypertension (1982) (64)
- An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia (2017) (63)
- Hyperuricemia and cardiovascular disease risk (2014) (61)
- Psyllium improves dyslipidaemia, hyperglycaemia and hypertension, while guar gum reduces body weight more rapidly in patients affected by metabolic syndrome following an AHA Step 2 diet (2009) (61)
- An update on hypertensive emergencies and urgencies (2015) (61)
- Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects. (2013) (60)
- Uric acid and Hypertension: An Update with Recommendations. (2020) (59)
- Lercanidipine in Hypertension (2005) (59)
- Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues (2015) (58)
- Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management. (2009) (57)
- Systemic hypotension and the development of acute sensorineural hearing loss in young healthy subjects. (2001) (57)
- Obesity and Cardiometabolic Risk Factors: From Childhood to Adulthood (2021) (57)
- Meniere's disease and the use of proton pump inhibitors. (2010) (56)
- Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia. (1995) (56)
- Interactions between hypercholesterolemia and hypertension: implications for therapy (2002) (56)
- Relative role of systolic, diastolic and pulse pressure as risk factors for cardiovascular events in the Brisighella Heart Study (2002) (55)
- Prevalence and control of hypertension in the general practice in Italy: updated analysis of a large database (2017) (55)
- Pharmacokinetics of ribavirin and urinary excretion of the major metabolite 1,2,4-triazole-3-carboxamide in normal volunteers. (1989) (55)
- Omega 3 Polyunsaturated Fatty Acids Supplementation and Blood Pressure Levels in Hypertriglyceridemic Patients with Untreated Normal-High Blood Pressure and With or Without Metabolic Syndrome: A Retrospective Study (2010) (53)
- Personalized medicine—a modern approach for the diagnosis and management of hypertension (2017) (52)
- Statins and blood pressure regulation (2001) (52)
- The Relationship Between Systolic Blood Pressure and Cardiovascular Risk—Results of the Brisighella Heart Study (2003) (51)
- Clinical impact of renin-angiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for COVID-19 (2020) (51)
- A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice (2007) (49)
- Trends in blood pressure control and antihypertensive treatment in clinical practice: the Brisighella Heart Study (2004) (49)
- Nutrients and Nutraceuticals for the Management of High Normal Blood Pressure: An Evidence-Based Consensus Document (2019) (48)
- Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study. (2007) (48)
- Application of polyunsaturated fatty acids in internal medicine: beyond the established cardiovascular effects (2012) (48)
- Effects of n-3 pufas on fasting plasma glucose and insulin resistance in patients with impaired fasting glucose or impaired glucose tolerance. (2016) (48)
- Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension (2020) (48)
- Urate-Lowering Drugs and Prevention of Cardiovascular Disease: The Emerging Role of Xanthine Oxidase Inhibition. (2016) (47)
- Integrated management of cardiovascular risk (2008) (46)
- Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment. (2017) (46)
- Trends in Prevalence, Awareness, Treatment, and Control of Blood Pressure Recorded From 2004 to 2014 During World Hypertension Day in Italy (2016) (46)
- Serum uric acid and impaired cognitive function in a cohort of healthy young elderly: data from the Brisighella Study (2015) (45)
- Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: Results from the Fosinopril in Acute Myocardial Infarction Study (1998) (45)
- Blood pressure levels and control in Italy: comprehensive analysis of clinical data from 2000–2005 and 2005–2011 hypertension surveys (2015) (45)
- A Systematic Review of Aspirin in Primary Prevention: Is It Time for a New Approach? (2014) (45)
- Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study. (2018) (44)
- 2012 Consensus Document of the Italian Society of Hypertension (SIIA): Strategies to Improve Blood Pressure Control in Italy (2013) (44)
- Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study (2011) (44)
- Serum uric acid levels are associated with cardiovascular risk score: A post hoc analysis of the EURIKA study. (2018) (44)
- Use of Lipid‐Lowering Drugs and Blood Pressure Control in Patients With Arterial Hypertension (2002) (44)
- Pulse pressure amplification, pressure waveform calibration and clinical applications. (2012) (43)
- Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk. (2018) (43)
- Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension (2021) (43)
- Prevalence of tinnitus in patients withhypertension and the impact of different anti hypertensive drugs on the incidence of tinnitus: A prospective, single-blind, observational study. (2005) (43)
- Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey (2021) (43)
- Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial (2020) (43)
- Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension (2020) (42)
- Uric acid and hypertension: a focused review and practical recommendations. (2019) (42)
- C-reactive protein levels in patients at cardiovascular risk: EURIKA study (2014) (42)
- Heart disease and changes in pulse wave velocity and pulse pressure amplification in the elderly over 80 years: the PARTAGE Study (2010) (42)
- Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study (2019) (42)
- LDL-oxidation, serum uric acid, kidney function and pulse-wave velocity: Data from the Brisighella Heart Study cohort. (2018) (41)
- Central hemodynamic modifications in diabetes mellitus. (2013) (41)
- Cardiovascular health in migrants: current status and issues for prevention. A collaborative multidisciplinary task force report (2014) (41)
- Urate lowering therapies in the treatment of gout: a systematic review and meta-analysis. (2016) (41)
- The role of physical activity in individuals with cardiovascular risk factors: an opinion paper from Italian Society of Cardiology-Emilia Romagna-Marche and SIC-Sport. (2019) (41)
- Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke. (2019) (41)
- The Effect of Xanthine Oxidase Inhibitors on Blood Pressure and Renal Function (2017) (40)
- Lactotripeptides effect on office and 24-h ambulatory blood pressure, blood pressure stress response, pulse wave velocity and cardiac output in patients with high-normal blood pressure or first-degree hypertension: a randomized double-blind clinical trial (2011) (40)
- Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease. (2007) (40)
- Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party. (1991) (39)
- ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects[S] (2013) (39)
- Serum Uric Acid and Cardiometabolic Disease: Another Brick in the Wall? (2017) (39)
- Uric Acid Amplifies Aβ Amyloid Effects Involved in the Cognitive Dysfunction/Dementia: Evidences From an Experimental Model In Vitro (2017) (38)
- COVID-19-Related Quarantine Effect on Dietary Habits in a Northern Italian Rural Population: Data from the Brisighella Heart Study (2021) (38)
- Comparison Between Zofenopril and Ramipril in Combination With Acetylsalicylic Acid in Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results of a Randomized, Double‐Blind, Parallel‐Group, Multicenter, European Study (SMILE‐4) (2012) (37)
- The PANDORA study: peripheral arterial disease in patients with non-high cardiovascular risk (2011) (37)
- Italian Society of Rheumatology recommendations for the management of gout. (2013) (37)
- Clinical Effects of Xanthine Oxidase Inhibitors in Hyperuricemic Patients (2020) (37)
- Medication adherence in hypertension. (2019) (37)
- Leisure-time physical activity and cardiovascular disease mortality: the Brisighella Heart Study (2012) (37)
- Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction. (2003) (37)
- Effect of apple polyphenols on vascular oxidative stress and endothelium function: a translational study. (2017) (36)
- Serum lipoprotein(a) level as long-term predictor of cardiovascular mortality in a large sample of subjects in primary cardiovascular prevention: data from the Brisighella Heart Study. (2017) (36)
- Uric acid is linked to cardiometabolic risk factors in overweight and obese youths (2018) (36)
- Middle-Term Dietary Supplementation with Red Yeast Rice Plus Coenzyme Q10 Improves Lipid Pattern, Endothelial Reactivity and Arterial Stiffness in Moderately Hypercholesterolemic Subjects (2016) (36)
- Improved Tolerability of the Dihydropyridine Calcium-Channel Antagonist Lercanidipine: The Lercanidipine Challenge Trial (2003) (36)
- A brief history of uric acid: From gout to cardiovascular risk factor. (2015) (36)
- Tolerability of Nebivolol in Head-To-Head Clinical Trials Versus Other Cardioselective β-Blockers in the Treatment of Hypertension (2005) (35)
- Captopril and hydrochlorothiazide: rationale for their combination. (1987) (34)
- Achievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention: Analysis of a large real practice database in Italy. (2019) (34)
- Effects of antihypertensive drugs on central blood pressure in humans: a preliminary observation. (2013) (34)
- A Randomized Placebo-Controlled Clinical Trial to Evaluate the Medium-Term Effects of Oat Fibers on Human Health: The Beta-Glucan Effects on Lipid Profile, Glycemia and inTestinal Health (BELT) Study (2020) (34)
- Factors associated with the development of stable hypertension in young borderline hypertensives (1996) (34)
- Serum uric acid and other short-term predictors of electrocardiographic alterations in the Brisighella Heart Study cohort. (2015) (34)
- Effect of a short-term dietary supplementation with phytosterols, red yeast rice or both on lipid pattern in moderately hypercholesterolemic subjects: a three-arm, double-blind, randomized clinical trial (2017) (33)
- Fatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart Study. (2018) (33)
- Interaction between serum cholesterol levels and the renin–angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure (2007) (33)
- Interaction between low-density lipoprotein-cholesterolaemia, serum uric level and incident hypertension: data from the Brisighella Heart Study. (2019) (33)
- Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update (2021) (33)
- Lipid-lowering and anti-inflammatory effects of omega 3 ethyl esters and krill oil: a randomized, cross-over, clinical trial (2016) (32)
- Effects of the early administration of zofenopril on onset and progression of congestive heart failure in patients with anterior wall acute myocardial infarction. The SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation. (1996) (32)
- Nutraceuticals and blood pressure control: a European Society of Hypertension position document. (2020) (31)
- Low Rates of Both Lipid-Lowering Therapy Use and Achievement of Low-Density Lipoprotein Cholesterol Targets in Individuals at High-Risk for Cardiovascular Disease across Europe (2015) (31)
- Rebound insomnia after abrupt discontinuation of hypnotic treatment: double‐blind randomized comparison of zolpidem versus triazolam (1996) (31)
- Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention. (2017) (31)
- MENIERE’S DISEASE: UPDATE OF ETIOPATHOGENETIC THEORIES AND PROPOSAL OF A POSSIBLE MODEL OF EXPLANATION (2010) (31)
- A review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases (2004) (30)
- From risk factor assessment to cardiovascular disease risk and mortality modification: the first 40 years of the Brisighella Heart Study (2011) (30)
- Interaction between low-density lipoprotein-cholesterolaemia, serum uric level and incident hypertension: data from the Brisighella Heart Study. (2019) (30)
- Serum cholesterol levels, blood pressure response to stress and incidence of stable hypertension in young subjects with high normal blood pressure (2004) (30)
- Polypill, hypertension and medication adherence: The solution strategy? (2018) (29)
- Renin-angiotensin system at the crossroad of hypertension and hypercholesterolemia. (2017) (29)
- Pharmacotherapeutic approaches for decompensated heart failure: a role for the calcium sensitiser, levosimendan? (2003) (29)
- Evidence-based medicine and ACE inhibition. (1998) (29)
- Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA) (2010) (29)
- Serum uric acid is inversely proportional to estimated stroke volume and cardiac output in a large sample of pharmacologically untreated subjects: data from the Brisighella Heart Study (2014) (28)
- Effect of Lactotripeptides (Isoleucine-Proline-Proline/Valine-Proline-Proline) on Blood Pressure and Arterial Stiffness Changes in Subjects with Suboptimal Blood Pressure Control and Metabolic Syndrome: A Double-Blind, Randomized, Crossover Clinical Trial. (2016) (28)
- Effect of Bempedoic Acid on Serum Uric Acid and Related Outcomes: A Systematic Review and Meta-analysis of the available Phase 2 and Phase 3 Clinical Studies (2020) (28)
- Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: results of a meta-analysis of 845 patients. FAMIS, CAPTIN and CATS Investigators. (2000) (28)
- Hyperuricemia: a novel old disorder—relationship and potential mechanisms in heart failure (2019) (27)
- Interactions between hypercholesterolemia and hypertension: implications for therapy. (2002) (27)
- Three‐arm, placebo‐controlled, randomized clinical trial evaluating the metabolic effect of a combined nutraceutical containing a bergamot standardized flavonoid extract in dyslipidemic overweight subjects (2019) (27)
- The role of uric acid in the development of cardiovascular disease (2015) (27)
- Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects (2016) (27)
- Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial (2016) (26)
- Hyperuricemia, urate deposition and the association with hypertension (2015) (26)
- Evidence of Clinically Relevant Efficacy for Dietary Supplements and Nutraceuticals (2013) (26)
- Arterial Stiffness, Sugar-Sweetened Beverages and Fruits Intake in a Rural Population Sample: Data from the Brisighella Heart Study (2019) (26)
- Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: Results of a meta-analysis of 845 patients (2001) (26)
- Gender difference in hepatic steatosis index and lipid accumulation product ability to predict incident metabolic syndrome in the historical cohort of the Brisighella Heart Study. (2013) (26)
- Increased storage of iron and anaemia in rheumatoid arthritis: usefulness of desferrioxamine. (1984) (26)
- Uricaemia and ejection fraction in elderly heart failure outpatients (2014) (25)
- Hemodynamic and neurohumoral profile in patients with different types of hypertension in pregnancy (2011) (25)
- Hypolipidemic effects of long-term antihypertensive treatment with captopril. A prospective study. (1988) (25)
- Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project (2021) (25)
- Long-term effect of a dietary education program on postmenopausal cardiovascular risk and metabolic syndrome: the Brisighella Heart Study. (2010) (25)
- Prevalence of peripheral arterial disease in subjects with moderate cardiovascular risk: Italian results from the PANDORA study Data from PANDORA (Prevalence of peripheral Arterial disease in subjects with moderate CVD risk, with No overt vascular Diseases nor Diabetes mellitus) (2011) (24)
- Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study (2021) (24)
- Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study (2018) (24)
- Intralymphocytic sodium concentration: a sensitive index to identify young subjects at risk of hypertension. (1981) (24)
- Effects of treatment strategy on endothelial function. (2010) (24)
- Antianemic and potential anti-inflammatory activity of desferrioxamine: possible usefulness in rheumatoid arthritis. (1986) (24)
- The Medical and Endovascular Treatment of Atherosclerotic Renal Artery Stenosis (METRAS) study: rationale and study design (2012) (24)
- Inner ear dysfunction of uncertain origin: a multidisciplinary approach could give something more. (2009) (24)
- Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study (2020) (24)
- Short-term effects of a combined nutraceutical of insulin-sensitivity, lipid level and indexes of liver steatosis: a double-blind, randomized, cross-over clinical trial (2015) (24)
- The management of hyperuricemia: back to the pathophysiology of uric acid (2017) (24)
- Hepatic Steatosis Index and Lipid Accumulation Product as middle-term predictors of incident metabolic syndrome in a large population sample: data from the Brisighella Heart Study (2013) (24)
- Effects of allopurinol and febuxostat on cardiovascular mortality in elderly heart failure patients (2019) (23)
- Relationship between blood pressure, cholesterolemia and serum apolipoprotein B in a large population sample: the Brisighella Heart Study (2012) (23)
- Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update. (2021) (22)
- The steroid profile of adrenal incidentalomas: subtyping subjects with high cardiovascular risk. (2019) (22)
- Short-Term Impact of a Combined Nutraceutical on Cognitive Function, Perceived Stress and Depression in Young Elderly with Cognitive Impairment: A Pilot, Double-Blind, Randomized Clinical Trial. (2017) (22)
- Effect of spontaneous changes in dietary components and lipoprotein(a) levels: Data from the Brisighella Heart Study. (2017) (22)
- Antithrombotic Therapy and Major Adverse Limb Events in Patients With Chronic Lower Extremity Arterial Disease: Systematic Review and Meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working (2019) (22)
- Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product (2017) (22)
- Serum LDL cholesterol levels and new onset of arterial hypertension: an 8‐year follow‐up (2014) (22)
- Post acute myocardial infarction: the Fosinopril in Acute Myocardial Infarction Study (FAMIS). (1997) (22)
- Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial (2017) (22)
- Association of Hypertriglyceridemia with All‐Cause Mortality and Atherosclerotic Cardiovascular Events in a Low‐Risk Italian Population: The TG‐REAL Retrospective Cohort Analysis (2020) (21)
- Cardiovascular risk and hypertension control in Italy. Data from the 2015 World Hypertension Day. (2017) (21)
- The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk (2021) (21)
- Hemodynamic effects of lactotripeptides from casein hydrolysate in Mediterranean normotensive subjects and patients with high-normal blood pressure: a randomized, double-blind, crossover clinical trial. (2010) (21)
- Zofenopril and incidence of cough: a review of published and unpublished data (2011) (21)
- [Disease management for heart failure patients: role of wireless technologies for telemedicine. The ICAROS project]. (2007) (21)
- Awareness of major cardiovascular risk factors and its relationship with markers of vascular aging: Data from the Brisighella Heart Study. (2020) (21)
- Association Between the Serum Uric Acid Levels and Lacunar Infarcts in the Elderly (2018) (21)
- Effect of a combined nutraceutical containing Orthosiphon stamineus effect on blood pressure and metabolic syndrome components in hypertensive dyslipidaemic patients: a randomized clinical trial. (2012) (20)
- Do ACE inhibitors or angiotensin II antagonists reduce total mortality and arrhythmic mortality? A critical review of controlled clinical trials (2002) (20)
- Long-term effectiveness and safety of a nutraceutical based approach to reduce cholesterolemia in statin intolerant subjects with and without metabolic syndrome. (2009) (20)
- Renal Artery Denervation for Treating Resistant Hypertension (2012) (20)
- Tinnitus in elderly patients and prognosis of mild-to-moderate congestive heart failure: a cross-sectional study with a long-term extension of the clinical follow-up (2011) (20)
- Post-partum evaluation of maternal cardiac function after severe preeclampsia (2014) (20)
- Effects of alpidem in anxious elderly outpatients: a double-blind, placebo-controlled trial. (1992) (20)
- Beneficial effects of listening to classical music in patients with heart failure: a randomized controlled trial. (2019) (20)
- Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study (2008) (20)
- Effects of early angiotensin-converting enzyme inhibition in patients with non-ST-elevation acute anterior myocardial infarction. (2006) (20)
- Prevalence of peripheral arterial disease in patients at non-high cardiovascular risk. Rationale and design of the PANDORA study (2010) (20)
- Additional therapy for cholesterol lowering in ezetimibe-treated, statin-intolerant patients in clinical practice: results from an internal audit of a university lipid clinic (2016) (19)
- Palaeopathology of the earlobe crease (Frank's sign): New insights from Renaissance art. (2017) (19)
- Serum uric acid and markers of low-density lipoprotein oxidation in nonsmoking healthy subjects: data from the Brisighella Heart Study. (2014) (19)
- Novel antidiabetic drugs and cardiovascular risk: Primum non nocere. (2016) (19)
- High-performance liquid chromatographic determination of ribavirin in serum and urine and of its urinary metabolite 1,2,4-triazole-3-carboxamide. (1987) (19)
- The older patient with hypertension: care and cure (2012) (19)
- Long-term clinical experience with zofenopril (2012) (19)
- The Treatment of Hypertension in Pregnancy (2002) (18)
- Relationship between tissue glycation measured by autofluorescence and pulse wave velocity in young and elderly non-diabetic populations. (2012) (18)
- Independent Determinants of Maternal and Fetal Outcomes in a Sample of Pregnant Outpatients With Normal Blood Pressure, Chronic Hypertension, Gestational Hypertension, and Preeclampsia (2015) (18)
- Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter pylori: A Literature Review (2021) (18)
- Persistence on Treatment and Blood Pressure Control with Different First-Line Antihypertensive Treatments: A Prospective Evaluation (2007) (18)
- Uric Acid and Hypertension: Prognostic Role and Guide for Treatment (2021) (18)
- Profile of evolocumab and its potential in the treatment of hyperlipidemia (2015) (18)
- Maternal cardiac evaluation during uncomplicated twin pregnancy with emphasis on the diastolic function. (2015) (18)
- Leptin, Resistin, and Proprotein Convertase Subtilisin/Kexin Type 9 (2020) (18)
- Current pharmacotherapeutic options for primary dyslipidemia in adults (2019) (18)
- The Role of Uric Acid in Acute and Chronic Coronary Syndromes (2021) (18)
- Persistence of treatment and blood pressure control in elderly hypertensive patients treated with different classes of antihypertensive drugs. (2007) (18)
- Differing dosages of captopril and hydrochlorothiazide in the treatment of hypertension: long-term effects metabolic values and intracellular electrolytes. (1985) (18)
- Programmed death-1 inhibition and atherosclerosis: can nivolumab vanish complicated atheromatous plaques? (2018) (18)
- Comparison of three devices for measuring blood pressure. (1985) (18)
- Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study (2020) (17)
- Effect of a sequential training programme on inflammatory, prothrombotic and vascular remodelling biomarkers in hypertensive overweight patients with or without metabolic syndrome (2009) (17)
- Emerging drugs for the treatment of hypercholesterolemia (2019) (17)
- Evaluation of twelve formulas for LDL-C estimation in a large, blinded, random Italian population. (2021) (17)
- Survival of myocardial infarction long-term evaluation (SMILE) study: rationale, design, organization, and outcome definitions. (1994) (17)
- Do we need ‘new’ omega-3 polyunsaturated fatty acids formulations? (2015) (17)
- Ferrari Corporate Wellness Program: Results of a Pilot Analysis and the “Drag” Impact in the Workplace (2018) (17)
- Improvement in arterial stiffness after short-term treatment with PCSK9 inhibitors. (2019) (17)
- Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party. (1998) (16)
- Anti‐Ischemic Effects of Angiotensin‐Converting Enzyme Inhibitors: A Future Therapeutic Perspective (2001) (16)
- Kidney disease and inner ear impairment: a simpler and closer pathogenic analogy? (2012) (16)
- Red yeast rice and statin-intolerant patients. (2010) (16)
- Intralymphocytic sodium concentration as an index of response to stress and exercise in young subjects with borderline hypertension. (1981) (16)
- Blood Pressure and Metabolic Effect of a Combination of Lercanidipine with Different Antihypertensive Drugs in Clinical Practice (2012) (16)
- Long-term predictors of impaired fasting glucose and type 2 diabetes in subjects with family history of type 2 diabetes: a 12-years follow-up of the Brisighella Heart Study historical cohort. (2014) (16)
- Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection. (2020) (16)
- Effect of quantitative and qualitative diet prescription on children behavior after diagnosis of heterozygous familial hypercholesterolemia. (2019) (16)
- Diuretics in Meniere disease: a therapy or a potential cause of harm? (2011) (15)
- Dietary determinants of oxidized-low-density lipoprotein antibodies in a sample of pharmacologically untreated non-smoker subjects: data from the Brisighella heart study. (2013) (15)
- The Effect of Chorionicity on Maternal Cardiac Adaptation to Uncomplicated Twin Pregnancy: A Prospective Longitudinal Study (2018) (15)
- Effect of pistachio on brachial artery diameter and flow-mediated dilatation: A systematic review and meta-analysis of randomized, controlled-feeding clinical studies (2019) (15)
- Determinants of healing among patients with coronavirus disease 2019: the results of the SARS-RAS study of the Italian Society of Hypertension (2020) (15)
- ACE-inhibitors and atherosclerosis (1992) (15)
- Elevated serum uric acid concentration at discharge confers additive prognostic value in elderly patients with acute heart failure. (2018) (15)
- Short-Term Effects of Dry Extracts of Artichokeand Berberis in Hypercholesterolemic Patients Without Cardiovascular Disease. (2019) (15)
- Predictors of the Short-Term Effect of Isoleucine–Proline–Proline/Valine–Proline–Proline Lactotripeptides from Casein on Office and Ambulatory Blood Pressure in Subjects with Pharmacologically Untreated High-Normal Blood Pressure or First-Degree Hypertension (2012) (15)
- The association between blood pressure and lipid levels in Europe: European Study on Cardiovascular Risk Prevention and Management in Usual Daily Practice (2016) (15)
- Zofenopril: A Review of the Evidence of its Benefits in Hypertension and Acute Myocardial Infarction (2000) (15)
- Rate of control of LDL cholesterol and incident hypertension requiring antihypertensive treatment in hypercholesterolemic subjects in daily clinical practice (2014) (15)
- Sex hormones and adipokines in healthy pre-menopausal, post-menopausal and elderly women, and in age-matched men: Data from the Brisighella Heart Study (2011) (15)
- Possible role of HMG-CoA reductase inhibitors for the treatment of sudden sensorineural hearing loss (SSHL). (2002) (15)
- Pain and Frailty in Hospitalized Older Adults (2020) (15)
- Determination of diclofenac in human plasma by selected ion monitoring. (1991) (15)
- Achievement of lipoprotein goals among patients with metabolic syndrome at high cardiovascular risk across Europe. The EURIKA study. (2013) (15)
- Sacubitril/valsartan improves both functional and echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction (2019) (14)
- Is tinnitus useful in early detection of incoming heart decompensation? (2006) (14)
- Relationship Between Serum Uric Acid and Electrocardiographic Alterations in a Large Sample of General Population: Data From the Brisighella Heart Study (2015) (14)
- Clinical Management of Patients with Hypertension and High Cardiovascular Risk (2014) (14)
- Italian Society of Arterial Hypertension (SIIA) Position Paper on the Role of Renal Denervation in the Management of the Difficult-to-Treat Hypertensive Patient (2020) (14)
- Peripartum management of hypertension. A position paper of the ESC Council on Hypertension and the European Society of Hypertension. (2019) (14)
- Efficacy and Safety of Zofenopril Versus Ramipril in the Treatment of Myocardial Infarction and Heart Failure: A Review of the Published and Unpublished Data of the Randomized Double-Blind SMILE-4 Study (2018) (14)
- Fixed combinations of delapril plus indapamide vs fosinopril plus hydrochlorothiazide in mild to moderate essential hypertension (2002) (14)
- Plasma concentrations of atrial natriuretic factor in normal pregnancy and early puerperium. (1989) (14)
- Association between self-reported snoring and arterial stiffness: data from the Brisighella Heart Study (2016) (14)
- Continuous ultrafiltration for congestive heart failure: the CUORE trial. (2014) (14)
- Potential Use of ACE Inhibitors After Acute Myocardial Infarction (1989) (14)
- May Measurement Month 2017: Results of 39 national blood pressure screening programmes (2019) (14)
- Change gout: how to deal with this “silently-developing killer” in everyday clinical practice (2018) (14)
- Impaired vasodilator capacity and exaggerated pressor response to isometric exercise in subjects with family history of hypertension. (1988) (14)
- Renal protection in chronic heart failure: focus on sacubitril/valsartan (2021) (14)
- Prevalence and Control of Hypertension in Different Macro-Areas in Italy: Analysis of a Large Database by the General Practice (2016) (14)
- Hyperuricemia is associated with increased hospitalization risk and healthcare costs: Evidence from an administrative database in Italy. (2016) (14)
- Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry (2020) (13)
- Hyperuricaemia and vascular risk: the debate continues. (2019) (13)
- Acute Administration of Angiotensin Converting Enzyme Inhibitors in Thrombolysed Myocardial Infarction Patients Is Associated with a Decreased Incidence of Heart Failure, but an Increased Re-Infarction Risk (2005) (13)
- Effect of a Lipid-Lowering Nutraceutical on Pulse-Wave-Velocity in Hypercholesterolemic Patients with or without Chronic Kidney Disease (2013) (13)
- Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies (2018) (13)
- Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril. (2010) (13)
- Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter pylori (2020) (13)
- Nation-wide hypertension screening in Italy: data from May Measurements Month 2017—Europe (2019) (13)
- Short-Term Hemodynamic Effects of Modern Wheat Products Substitution in Diet with Ancient Wheat Products: A Cross-Over, Randomized Clinical Trial (2018) (13)
- The Role of Irbesartan in the Treatment of Patients with Hypertension (2012) (13)
- Prospective evaluation of the effect of statins on blood pressure control in hypertensive patients in clinical practice. (2010) (13)
- Efficacy of Zofenopril Compared With Placebo and Other Angiotensin-converting Enzyme Inhibitors in Patients With Acute Myocardial Infarction and Previous Cardiovascular Risk Factors: A Pooled Individual Data Analysis of 4 Randomized, Double-blind, Controlled, Prospective Studies (2017) (12)
- Prevalence and Incidence of Atrial Fibrillation in a Large Cohort of Adrenal Incidentalomas: A Long-Term Study. (2020) (12)
- Inner ear symptoms: can we use them to approach cardiovascular diseases? (2014) (12)
- Modifications in drug adherence after switch to fixed-dose combination of perindopril/amlodipine in clinical practice. Results of a large-scale Italian experience. The amlodipine-perindopril in real settings (AMPERES) study (2018) (12)
- LEPTIN, RESISTIN, AND PCSK9 - THE ROLE OF STAT3. (2020) (12)
- Serum cholesterol levels on admission and survival in patients with acute myocardial infarction treated with zofenopril: a post hoc analysis of the Survival of Myocardial Infarction Long‐term Evaluation trial (2009) (12)
- β-blockade in Hypertension and congestive heart failure (2001) (12)
- Pharmacokinetics, pharmacodynamics and clinical efficacy of non-statin treatments for hypercholesterolemia (2018) (12)
- The Impact of Uric Acid and Hyperuricemia on Cardiovascular and Renal Systems. (2021) (12)
- Use of captopril to reduce serum lipids in hypertensive patients with hyperlipidemia. (1988) (12)
- Combined nutraceutical approach to postmenopausal syndrome and vascular remodeling biomarkers. (2013) (12)
- Factors associated with 2-year persistence in fully non reimbursed lipid-lowering treatments. (2014) (12)
- Direct Renin Inhibition (2011) (12)
- Adipokines and Sexual Hormones Associated with the Components of the Metabolic Syndrome in Pharmacologically Untreated Subjects: Data from the Brisighella Heart Study (2011) (12)
- Rationale for the Use of a Fixed-Dose Combination in the Management of Hypertension (2012) (12)
- PERIOPERATIVE SCREENING AND MANAGEMENT OF HYPERTENSIVE PATIENTS (2010) (12)
- Serum uric acid and acute coronary syndrome: Is there a role for functional markers of residual cardiovascular risk? (2018) (12)
- Effects of sacubitril valsartan on clinical and echocardiographic parameters of outpatients with heart failure and reduced ejection fraction (2020) (12)
- Metabolic Syndrome, Adipokines and Hormonal Factors in Pharmacologically Untreated Adult Elderly Subjects from the Brisighella Heart Study Historical Cohort (2012) (12)
- Angiopoietin-like 3 and subclinical peripheral arterial disease: Evidence from the Brisighella Heart Study (2020) (12)
- Sex differences in arterial hypertension (2022) (11)
- Fixed combination of lercanidipine and enalapril in the management of hypertension: focus on patient preference and adherence (2012) (11)
- One year of SARS-CoV-2 and lung ultrasound: what has been learned and future perspectives (2021) (11)
- Renin‐Angiotensin System Inhibitors in Patients With COVID‐19: A Meta‐Analysis of Randomized Controlled Trials Led by the International Society of Hypertension (2022) (11)
- Comparison of two automatic devices and the standard mercury sphygmomanometer in hypertensive patients. (1985) (11)
- Effect of zofenopril and ramipril on cardiovascular mortality in patients with chronic heart failure. (2013) (11)
- Application of the Sampson equation to estimate LDL-C in children: Comparison with LDL direct measurement and Friedewald equation in the BLIP study. (2021) (11)
- Berberine and Monacolin Effects on the Cardiovascular Risk Profile of Women with Oestroprogestin-Induced Hypercholesterolemia (2014) (11)
- The Complex Relationship Between Serum Uric Acid, Endothelial Function and Small Vessel Remodeling in Humans (2020) (11)
- Cardiovascular Prevention in Subjects with Impaired Fasting Glucose or Impaired Glucose Tolerance (2010) (11)
- Is there a role for atrial peptides in the labyrinthine "disease"? (2006) (11)
- The future of febuxostat after the Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES) trial: who CARES? (2018) (11)
- Could echocardiography yield a cardiovascular profile of the tinnitus prone subject? (2008) (11)
- Non-steroidal antiinflammatory drug therapy: advantages and disadvantages of long half-life drugs versus slow-release formulations. (1986) (11)
- Diagnostic and Therapeutic Approach to Sleep Disorders, High Blood Pressure and Cardiovascular Diseases: A Consensus Document by the Italian Society of Hypertension (SIIA) (2021) (11)
- Haemodynamic profile of young subjects with transient tinnitus (2009) (11)
- Long-term efficacy and tolerability of a multicomponent lipid-lowering nutraceutical in overweight and normoweight patients (2012) (11)
- Recent evidence of the role of omega-3 polyunsaturated fatty acids on blood pressure control and hypertension-related complications (2006) (11)
- Hyperuricemia and chronic kidney disease: to treat or not to treat (2021) (10)
- Beta-blockade in hypertension and congestive heart failure. (2001) (10)
- Inequalities in enrollment of women and racial minorities in trials testing uric acid lowering drugs. (2021) (10)
- A different modulation of vascular endothelial growth factor (VEGF) activation in response to hypoxia could cause different clinical pictures in inner ear disorders (2010) (10)
- Prospective meta-analysis protocol on randomised trials of renin–angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of Hypertension (2021) (10)
- Uric acid as a cross-over between rheumatology and cardiovascular disease (2013) (10)
- Cardioprotective role of zofenopril in patients with acute myocardial infarction: a pooled individual data analysis of four randomised, double-blind, controlled, prospective studies (2015) (10)
- Role of nebivolol in the control and management of central aortic blood pressure in hypertensive patients (2017) (10)
- Gastric type proton pump of the inner ear: Its possible involvement in labyrinthine disorders (2008) (10)
- Efficacy and tolerability of a combined lipid-lowering nutraceutical on cholesterolemia, hs-CRP level and endothelial function in moderately hypercholesterolemic subjects. (2016) (10)
- Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study (2013) (10)
- Short-term plasma renin activity suppression by saline and release of a plasma endogenous Na/K ATPase inhibitor in essential hypertension. (1990) (10)
- Effects of Treatment with Zofenopril in Men and Women with Acute Myocardial Infarction: Gender Analysis of the SMILE Program (2014) (10)
- Cardiovascular Risk Reduction with Icosapent Ethyl. (2019) (9)
- Ace-inhibitors and experimental atherosclerosis. (1993) (9)
- Hypertension: management perspectives (2012) (9)
- Terlipressin infusion induces Tako-Tsubo syndrome in a cirrhotic man with hepato-renal syndrome (2011) (9)
- Uric acid and cardiovascular diseases (2008) (9)
- Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program (2018) (9)
- Can Lung Ultrasound be Used to Screen for Pulmonary Embolism in Patients with SARS-CoV-2 Pneumonia? (2020) (9)
- Uric Acid and Risk of Cardiovascular Disease: A Question of Start and Finish. (2021) (9)
- A Critical Review of Nebivolol and its Fixed-Dose Combinations in the Treatment of Hypertension (2018) (9)
- Emerging biologic therapies for hypercholesterolaemia (2017) (9)
- NoSAS score associated with arterial stiffness in a large cohort of healthy individuals. (2016) (9)
- Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensives (2009) (9)
- Visual and Hearing Impairment Are Associated With Delirium in Hospitalized Patients: Results of a Multisite Prevalence Study. (2020) (9)
- Double-blind preference and compliance multicentre study in osteoarthritis: once-a-day treatment (1985) (9)
- Atrial natriuretic factor modulates the plasma levels of a Na+/K+ATPase inhibitor in volume expanded borderline hypertensives. (1991) (8)
- Is it Possible to Significantly Modify Blood Pressure with a Combined Nutraceutical on Top of a Healthy Diet? The Results of a Pilot Clinical Trial (2018) (8)
- The association of uric acid with mortality modifies at old age: data from the uric acid right for heart health (URRAH) study (2021) (8)
- Pattern of peripheral venous response to volume expansion in borderline systemic hypertension. (1990) (8)
- Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the Uric Acid Right for Heart Health (URRAH) study (2021) (8)
- Efficacy and safety of inclisiran a newly approved FDA drug: a systematic review and pooled analysis of available clinical studies (2022) (8)
- Insulin Signaling in Arthritis (2021) (8)
- Plasma concentrations of atrial natriuretic factor and hemodynamics in pregnancy-induced hypertension. (1991) (8)
- Influence of lifestyle measures on hypertriglyceridaemia. (2009) (8)
- Morbidity and mortality in a population of patients affected by heart failure and chronic obstructive pulmonary disease: an observational study (2019) (8)
- The Effect of Ketogenic Diet on Inflammatory Arthritis and Cardiovascular Health in Rheumatic Conditions: A Mini Review (2021) (8)
- Purification of a Na+/K+ ATPase inhibitor from borderline hypertensives' plasma. (1990) (8)
- The use of zofenopril and fosinopril in acute myocardial infarction and carotid artery disease. (1994) (8)
- Cough and ACE Inhibitors: The Truth Beyond Placebo (2019) (8)
- Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin‐treated hypertensive hypercholesterolemic patients (2009) (8)
- Uric Acid and Hypertension: a Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk (2022) (8)
- May Measurement Month 2019: results of blood pressure screening from 47 countries (2021) (8)
- COVID-19-related quarantine effect on dietary habits in a northern italian rural population: Data from the BRISIGHELLA heart study (2021) (8)
- Attitudes and preferences for the clinical management of hypertension and hypertension-related cardiac disease in general practice: results of the Italian Hypertension and Heart Survey (2014) (8)
- Early Treatment With Zofenopril and Ramipril in Combination With Acetyl Salicylic Acid in Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results of a 5-Year Follow-up of Patients of the SMILE-4 Study (2017) (8)
- Lipoprotein(a) and Other Serum Lipid Subfractions Influencing Primary Patency after Infrainguinal Percutaneous Transluminal Angioplasty (2009) (7)
- A Randomized, Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO®) on LDL Cholesterol Levels and Lipid Pattern in Subjects with Sub-Optimal Blood Cholesterol Levels (NATCOL Study) (2020) (7)
- A new approach to quantify cardiovascular response in dentistry. (1991) (7)
- New disappearance of complicated atheromatous plaques on rechallenge with PD-1/PD-L1 axis blockade in non-small cell lung cancer patient: follow up of an unexpected event (2020) (7)
- Acute Kidney Injury in Pediatric Diabetic Kidney Disease (2021) (7)
- Hypertension in stroke survivors and associations with national premature stroke mortality: data for 2·5 million participants from multinational screening campaigns. (2022) (7)
- Angiotensin-Converting Enzyme Inhibition: Beyond Blood Pressure Control—The Role of Zofenopril (2020) (7)
- Preexisting Oral Anticoagulant Therapy Ameliorates Prognosis in Hospitalized COVID-19 Patients (2021) (7)
- Compliance with therapy in hypertensive patients (2006) (7)
- Effects of Moderate Salt Restriction and High Potassium Intake on Intralymphocytic Sodium Content and Pressor Response to Stress in Borderline Hypertension (1982) (7)
- THE USE OF LERCANIDIPINE CAN IMPROVE THE INDIVIDUAL TOLERABILITY TO DIHYDROPIRIDINE CALCIUM BLOCKERS IN HYPERTENSIVE PATIENTS: P3.18 (2000) (7)
- Serum uric acid levels threshold for mortality in diabetic individuals: The URic acid Right for heArt Health (URRAH) project. (2022) (7)
- Tinnitus as a warning for preventing vasovagal syncope. (2009) (7)
- Influence of metabolic syndrome superposition on familial combined hyperlipoproteinemia cardiovascular complication rate (2013) (7)
- Comparison of three different methods of monitoring unwanted effects during antihypertensive therapy. (1984) (7)
- Real-World Hypertension Prevalence, Awareness, Treatment, and Control in Adult Diabetic Individuals: An Italian Nationwide Epidemiological Survey (2021) (7)
- Strategies to meet the need for long-term data (2016) (7)
- Primary vascular dysregulation syndrome: Possible implications for inner ear acute diseases? (2015) (7)
- [Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention]. (2014) (7)
- Possible influence on heart rate on tinnitus. (2009) (7)
- Relationship between Lipid Phenotypes, Overweight, Lipid Lowering Drug Response and KIF6 and HMG-CoA Genotypes in a Subset of the Brisighella Heart Study Population (2017) (7)
- Prevalent Seasoning and Cooking Fats, Arterial Stiffness and Blood Lipid Pattern in a Rural Population Sample: Data from the Brisighella Heart Study (2020) (7)
- Effects of Losartan and Chlorthalidone on Blood Pressure and Renal Vascular Resistance Index in Non-Diabetic Patients with Essential Hypertension and Normal Renal Function (2004) (6)
- Zofenopril plus hydrochlorothiazide combination in the treatment of hypertension: an update (2014) (6)
- Importance of plasma renin activity suppression and venous distensibility on pressor and natriuretic responses to intravenous salt load in borderline hypertension. (1988) (6)
- Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1. (2019) (6)
- [Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018]. (2018) (6)
- Misinterpreting data in lipidology in the era of COVID-19 (2020) (6)
- Attitudes and preferences for the clinical management of patients with hypertension and hypertension with chronic obstructive pulmonary disease in Italy: main results of a survey questionnaire (2015) (6)
- Pharmacokinetic drug evaluation of anacetrapib for the treatment of dyslipidemia (2017) (6)
- Hypertension and Dyslipidemia Combined Therapeutic Approaches (2022) (6)
- Safety implications of combining ACE inhibitors with thiazides for the treatment of hypertensive patients (2020) (6)
- Clinical Management of Hypertension in Pregnancy (2013) (6)
- Uric acid and estimate of renal function. Let's stick together. (2020) (6)
- Effects of intensive urate lowering therapy with febuxostat in comparison with allopurinol on pulse wave velocity in patients with gout and increased cardiovascular risk: the FORWARD study. (2021) (6)
- Blood Pressure Modulating Properties of Omega-3 Polyunsaturated Fatty Acids (PUFA) (2007) (6)
- Is the 2020 Sampson equation the best formula for LDL-C estimation? (2020) (6)
- Detection of familial combined hyperlipoproteinaemia patients in the Brisighella Heart Study historical cohort: An epidemiological approach (2007) (6)
- Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. (2022) (6)
- Central blood pressure as estimate of cardiovascular risk: potentials and limitations. (2008) (6)
- Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized “Z” Studies (2017) (6)
- Early and late angiotensin-converting enzyme inhibition in acute myocardial infarction. (1993) (6)
- National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities (2014) (6)
- Clinical aspects of ACE inhibition in patients with acute myocardial infarction (1996) (6)
- Compliance to antihypertensive treatment and monotherapy. Behavoiur of the calcium-channel blocker lercanidipine. (2005) (5)
- [Prevention Italy 2021 - An update of the 2018 Consensus document and recommendations for the prevention of cardiovascular disease in Italy]. (2021) (5)
- Efficacy and tolerability of delapril plus indapamide versus lisinopril plus hydrochlorothiazide combination treatments in mild to moderate hypertension: a multicenter, randomized clinical study. (2003) (5)
- Interactions Between Hypertension and Hypercholesterolemia: From Epidemiology to Therapeutic Implications (2008) (5)
- Nutraceuticals with lipid-lowering activity: do they have any effect beyond cholesterol reduction? (2012) (5)
- Determinants of acute salt sensitivity in hypertension-prone men. (1991) (5)
- Complementary and Alternative Medicine for Hypertension (2005) (5)
- Attitudes and preferences for the clinical management of hypertension and hypertension-related cerebrovascular disease in the general practice: results of the Italian hypertension and brain survey (2017) (5)
- May Measurement Month 2018: results of blood pressure screening from 41 countries (2020) (5)
- Sunday, 26 August 2012 (2012) (5)
- New Opportunities for Monitoring Blood Pressure Control and Awareness in the Population: Insights from 12-Year Editions of the World Hypertension Day (2016) (5)
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. (2020) (5)
- Surprises in cardiology: efficacy of gliflozines in heart failure even in the absence of diabetes (2021) (5)
- Drugs and tinnitus: A review of a controversial matter (2010) (5)
- May Measurement Month 2019: an analysis of blood pressure screening results from Italy (2021) (5)
- Uric acid and early prevention of vascular diseases: Women under the looking glass. (2018) (5)
- Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4 (2013) (5)
- Pressor response to stress and exercise in the young: intracellular ion content relationships and prognostic implications. (1987) (5)
- Effect of Omega-3 Polyunsaturated Fatty Acids Treatment on Lipid Pattern of HIV Patients: A Meta-Analysis of Randomized Clinical Trials (2020) (5)
- Double blind controlled trial with oxmetidine and cimetidine in the short-term treatment of duodenal ulcer. (1981) (5)
- The Gut Microbiota and Vascular Aging: A State-of-the-Art and Systematic Review of the Literature (2022) (5)
- PHARMACOECONOMIC AND COST–BENEFIT ASPECTS (2008) (5)
- [Strategies for improving blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. 2012 Position paper of the Italian Society of Hypertension]. (2012) (5)
- Evolving concept of cardioprotection in myocardial infarction: from SMILE-1 to SMILE-5. (2013) (5)
- Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data (2006) (5)
- Central hemodynamics for risk reduction strategies: additive value over and above brachial blood pressure. (2014) (5)
- Combination therapy in the extended cardiovascular continuum: a focus on perindopril and amlodipine (2015) (5)
- Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids. (2019) (5)
- Zofenopril and ramipril in patients with left ventricular systolic dysfunction after acute myocardial infarction: A propensity analysis of the Survival of Myocardial Infarction Long-term Evaluation (SMILE) 4 study (2016) (4)
- High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid. (2021) (4)
- Update on management of hypokalemia and goals for the lower potassium level in patients with cardiovascular disease: A review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. (2021) (4)
- SHORT-TERM IMPACT OF A COMBINED NUTRACEUTICAL ON COGNITIVE FUNCTION, PERCEIVED STRESS AND DEPRESSION IN YOUNG ELDERLY WITH COGNITIVE IMPAIRMENT: A PILOT, DOUBLE-BLIND, RANDOMIZED CLINICAL TRIAL (2016) (4)
- Clinical management of patients with hypertension and high cardiovascular risk in specialised centers and in general practice. Analysis from an Italian Survey Questionnaire. (2015) (4)
- The influence of systemic circulation on hearing: The reliability of a different impact of microcirculatory defects and atherosclerosis. (2016) (4)
- Glyco‐metabolic control, inflammation markers, and cardiovascular outcomes in type 1 and type 2 diabetic patients on insulin pump or multiple daily injection (italico study) (2020) (4)
- Erratum to: Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril (2011) (4)
- Bioavailability of diclofenac sodium with vaginal administration in healthy women (1991) (4)
- P-463: Relationship between serum cholesterol and development of hypertension in the population of the Brisighella Heart Study (2003) (4)
- Hemodynamic and Humoral Effects of Chronic Antihypertensive Treatment with Fenquizone: Importance of Aldosterone Response (1990) (4)
- Optimizing Lipid Pattern by Adding a Combined Nutraceutical or Pravastatin to Fenofibrate Treatment in Hypertriglyceridemic Subjects: Single Site, Randomized, Open-Label, Post-Market Clinical Investigation (2018) (4)
- Captopril and oxprenolol in a fixed combination with thiazide diuretics: comparison of their antihypertensive efficacy and metabolic effects. (1984) (4)
- Vitamin D Supplementation and COVID-19 Outcomes: Mounting Evidence and Fewer Doubts (2022) (4)
- Hyperuricemia and mortality in heart failure: Is it time to change the route? (2020) (4)
- The association between serum uric acid levels and 10-year cardiovascular disease incidence: results from the ATTICA prospective study. (2021) (4)
- Ribavirin influence on theophylline plasma levels in adult and children. (1988) (4)
- Canrenone on cardiovascular mortality in congestive heart failure CanrenOne eFFects on cardiovascular mortality in patiEnts with congEstIve hearT failure: The COFFEE‐IT study (2019) (4)
- Fixed-dose combination of zofenopril plus hydrochlorothiazide vs. irbesartan plus hydrochlorothiazide in hypertensive patients with established metabolic syndrome uncontrolled by previous monotherapy. The ZAMES study (Zofenopril in Advanced MEtabolic Syndrome) (2016) (4)
- Omega-3 fatty acids: a promising possible treatment for Meniere's disease and other inner ear disorders of unknown origin? (2012) (4)
- Pulmonary embolism in patients with severe COVID-19 treated with intermediate- to full-dose enoxaparin: A retrospective study. (2020) (4)
- Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks. (2018) (4)
- Management of pregnancy-related hypertensive disorders in patients infected with SARS CoV-2: pharmacological and clinical issues (2020) (4)
- Omega-3 in Antiarrhythmic Therapy (2012) (4)
- Determinants of healing among patients with COVID-2019: the results of the SARS-RAS study of the Italian Society of Hypertension (2020) (4)
- Efficacy of zofenopril in combination with amlodipine in patients with acute myocardial infarction: a pooled individual patient data analysis of four randomized, double-blind, controlled, prospective studies (2018) (4)
- Atrial natriuretic factor response to acute volume expansion in borderline hypertension. Role of ACE-inhibition and changes in peripheral venous tone. (1993) (4)
- About plasma arginin vasopressin levels and Meniere's disease (2011) (4)
- New oral anticoagulants and prevention of thromboembolic events in patients with hypertension and atrial fibrillation: an appraisal (2017) (4)
- Investire in arte (2012) (4)
- Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry (2021) (4)
- Serum Uric Acid and Kidney Disease Measures Independently Predict Cardiovascular and Total Mortality: The Uric Acid Right for Heart Health (URRAH) Project (2021) (4)
- Population Health Needs Assessment and Healthcare Services Use in a 3 Years Follow-Up on Administrative and Clinical Data: Results from the Brisighella Heart Study (2014) (4)
- [BP.11.07] LDL-OXIDATION, SERUM URIC ACID AND PULSE-WAVE VELOCITY RELATIONSHIP IN CHRONIC KIDNEY DISEASE: DATA FROM THE BRISIGHELLA HEART STUDY COHORT (2017) (4)
- Irbesartan: a review of its use alone and in combination with hydrochlorothiazide (2006) (4)
- Plasma Na+-K+ ATPase inhibitory activity in normal and hypertensive subjects: relationship to intracellular electrolytes and blood pressure. (1985) (4)
- Serum Urate, Uricase, and Blood Pressure Control in Gout. (2019) (4)
- Cellular and humoral factors in borderline hypertension. (1986) (4)
- The new type 2 diabetes mellitus therapy: comparison between the two classes of drugs GLPR (glucagon-like peptide receptor) agonists and SGLT2 (sodium–glucose cotransporter 2) inhibitors (2020) (4)
- Long-Term Impact of Different Triple Combination Antihypertensive Medications on Blood Pressure Control, Metabolic Pattern and Incident Events: Data from the Brisighella Heart Study (2021) (4)
- Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study (2022) (4)
- The effect of the Angiotensin-Converting-Enzyme inhibitor Zofenopril on mortality after anterior myocardial infarction. (1995) (3)
- Abstract 14717: Double-blind, Randomized Comparison of Zofenopril vs. Ramipril in MI Patients Treated With ASA: The SMILE 4 Study and Subgroup Analysis (2011) (3)
- Randomised comparison of zofenopril and ramipril plus acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a post hoc analysis of the SMILE-4 Study in patients according to levels of left ventricular ejection fraction at entry (2015) (3)
- ACE inhibitors during and after myocardial infarction (1990) (3)
- RELATIONSHIP BETWEEN DIURETIC RELATED HYPERURICEMIA AND CARDIOVASCULAR EVENTS: DATA FROM THE URRAH (URIC ACID RIGHT FOR HEART HEALTH) STUDY (3)
- The Antihypertensive Mechanism of Diuretics (1987) (3)
- Berberine induced improvement in hepatic steatosis index in overweight dyslipidaemic patients treated with lipid-lowering nutraceuticals (2013) (3)
- [Effects of vasoconstrictors during local anesthesia]. (1990) (3)
- Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients. (2016) (3)
- A Risk-Benefit Assessment of ACE Inhibitor Therapy Post-Myocardial Infarction (1996) (3)
- Coffee and blood pressure: exciting news! (2022) (3)
- The “Early Treatment” Approach Reducing Cardiovascular Risk in Patients with Type 2 Diabetes: A Consensus From an Expert Panel Using the Delphi Technique (2021) (3)
- Which serum uric acid levels are associated with increased cardiovascular risk in the general adult population? (2020) (3)
- Short-Term Effect of a New Oral Sodium Hyaluronate Formulation on Knee Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial (2020) (3)
- Uric Acid and Chronic Kidney Disease: Still More to Do (2022) (3)
- May Measurement Month 2018: an analysis of blood pressure screening results from Italy (2020) (3)
- Modifications of intra- and extracellular sodium and potassium. A possible mechanism for the antihypertensive action of captopril and hydrochlorothiazide. (1985) (3)
- [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success]. (2005) (3)
- A randomized, double-blind study of alpidem vs placebo in the prevention and treatment of benzodiazepine withdrawal syndrome (1996) (3)
- The extent of regional wall motion abnormalities identifies patients at risk of extensive left ventricular remodeling: implications for the design of post myocardial infarction trials. (1999) (3)
- P-464: Hypercholesterolemia and progression of high-normal blood pressure to hypertension (2003) (3)
- Laboratory and Instrumental Risk Factors Associated with a Sudden Cardiac Death Prone ECG Pattern in the General Population: Data from the Brisighella Heart Study (2021) (3)
- The possible role of Vicorder® apparatus in the diagnostic protocol of inner ear diseases (2015) (3)
- Effect of Dietary Supplementation with Eufortyn® Colesterolo Plus on Serum Lipids, Endothelial Reactivity, Indexes of Non-Alcoholic Fatty Liver Disease and Systemic Inflammation in Healthy Subjects with Polygenic Hypercholesterolemia: The ANEMONE Study (2022) (3)
- [Renal denervation for the treatment of resistant hypertension: definition, patient selection and description of the procedure. 2012 Position paper of the Italian Society of Hypertension]. (2012) (3)
- Improving adherence with treatment-resistant hypertension (2021) (3)
- Improved blood pressure control in hypertensive and hypercholesterolemic patients treated with HMG-CoA reductase inhibitors (1998) (3)
- Peripheral Hemodynamic and Humoral Effects of Oral Zofenopril Calcium (SQ. 26,991) in Patients with Congestive Heart Failure (1989) (3)
- A nutraceutical based approach to reduce cholesterolaemia in patients previously intolerant of more than a statin: a pilot study (2008) (3)
- Synergistic actions between angiotensin-converting enzyme inhibitors and statins in atherosclerosis. (2021) (3)
- Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients. (2019) (3)
- Cardiometabolic Risks and Obesity in the Young. (2016) (3)
- Diabetes in the third millennium: prognosis improves, but juvenile forms are more frequent (2019) (3)
- Influence of captopril on intracellular ions--a possible mode of action. (1986) (3)
- Diets, Foods and Food Components’ Effect on Dyslipidemia (2021) (3)
- Prevalence and features of delirium in older patients admitted to rehabilitation facilities: a multicenter study (2022) (3)
- Acebutolol, atenolol and nadolol: comparison of their antihypertensive efficacy at rest and during exercice (1984) (3)
- Reply to ‘The case for evidence-based medicine for the association between hyperuricaemia and CKD’ (2020) (3)
- Coexisting Heart Failure and Chronic Obstructive Pulmonary Disease: Report of Two Cases Treated with Indacaterol/Glycopyrronium (2018) (3)
- LIFE (losartan intervention for endpoint reduction in hypertension) study and its substudies (2007) (3)
- Post COVID-19 irritable bowel syndrome (2022) (3)
- ANTIHYPERTENSIVE EFFICACY OF LACTOTRIPEPTIDES ASSUMED AS FUNCTIONAL FOODS: A META-ANALYSIS OF CURRENT AVAILABLE CLINICAL TRIALS: PP.23.425 (2010) (3)
- Cardiovascular risk factors and hearing impairment: a non-automatic correlation (2016) (3)
- 5C.02: PREVALENCE OF HYPERTENSION AND OTHER CARDIOVASCULAR RISK FACTORS IN PARTICIPANTS IN THE 2014 HYPERTENSION WORLD DAY CAMPAIGN IN ITALY (2015) (3)
- 2B.02: SERUM URIC ACID LEVEL, BUT NOT RENAL FUNCTION OR ARTERIAL STIFFNESS, IS ASSOCIATED TO WORSE BLOOD PRESSURE CONTROL IN GENERAL PRACTICE DATA FROM THE BRISIGHELLA HEART STUDY (2015) (3)
- Noninvasive instrumental evaluation of coenzyme Q10 phytosome on endothelial reactivity in healthy nonsmoking young volunteers: A double‐blind, randomized, placebo‐controlled crossover clinical trial (2022) (3)
- Uric acid and risk of myocardial infarction. A dynamic duo. (2020) (3)
- Correction to: Effect of a short-term dietary supplementation with phytosterols, red yeast rice or both on lipid pattern in moderately hypercholesterolemic subjects: a three-arm, double-blind, randomized clinical trial (2018) (3)
- Gout and CV disease: It is time to move on. (2018) (3)
- Long-term consequences of previous preeclampsia and complicated pregnancy: analysis of echocardiographic aspects. (2021) (2)
- Antihypertensive efficacy of two low dosages of hydrochlorothiazide in patients treated with captopril. (1985) (2)
- Correlation between plasma and tonsillar levels of cefroxadine. (1988) (2)
- World Hypertension Day 2021 in Italy: Results of a Nationwide Survey (2022) (2)
- Longitudinal trends in the prevalence of hyperuricaemia and chronic kidney disease in hypertensive and normotensive adults (2020) (2)
- Progress towards 3D bioprinting of tissue models for advanced drug screening: In vitro evaluation of drug toxicity and drug metabolism (2022) (2)
- [ACE inhibitors in the treatment of patients with acute myocardial infarct]. (1995) (2)
- [Metabolic syndrome and hypertension: prevention and treatment]. (2006) (2)
- Impact of serum uric acid levels on cardiovascular events and quality of life in patients with chronic coronary syndromes: Insights from a contemporary, prospective, nationwide registry. (2021) (2)
- 1061-87 Effects of zofenopril on ischemia following myocardial infarction: The SMILE study (2004) (2)
- How important are triglycerides as risk factors? (2017) (2)
- BLOOD PRESSURE CONTROL, UTERO-PLACENTAL HEMODYNAMIC AND FETAL OUTCOME IN PRE-ECLAMPTIC PATIENTS TREATED WITH NIFEDIPINE-GITS AND METHYLDOPA: P3.19 (2000) (2)
- Tinnitus in patients on therapy with proton pump inhibitors (PPI) and in PPI non-users (2014) (2)
- Reduction of High Cholesterol Levels by a Preferably Fixed-Combination Strategy as the First Step in the Treatment of Hypertensive Patients with Hypercholesterolemia and High/Very High Cardiovascular Risk: A Consensus Document by the Italian Society of Hypertension (2022) (2)
- Calcium channel antagonists in hypertension. (1989) (2)
- Is it the the renin-angiotensin-aldosterone blockade a comprehensive tool for the management of cardiovascular risk? (2004) (2)
- LDL-oxidation, serum uric acid and pulse-wave velocity relationship in chronic kidney disease: Data from the Brisighella heart study cohort. (2017) (2)
- [The SMILE study: the rationale, design, organization and definition of the objectives. Survival of Myocardial Infarction Long-term Evaluation]. (1993) (2)
- [The new lipid-lowering drugs: focus on monoclonal antibodies]. (2016) (2)
- [PP.19.05] PREHYPERTENSION IN EUROPEAN RURAL POPULATION - DATA FROM THE BRISGHELLA HEART STUDY (ITALY) AND ENAH STUDY (CROATIA) (2016) (2)
- Hypertension: quo vadis? (2012) (2)
- Severe hypercholesterolaemia in a paediatric patient with congenital analbuminaemia. (2019) (2)
- Possible Advantages Deriving from Patiromer Use in Hypertensive Patients Made Hyperkalemic by Renin–Angiotensin–Aldosterone Blocking Agents (2021) (2)
- Relationship between acute suppression of plasma renin activity and lymphocyte Na+:H+ exchange rate in young patients with borderline hypertension. (1994) (2)
- [OP.8E.07] MIDDLE-TERM DIETARY SUPPLEMENTATION WITH RED YEAST RICE PLUS COENZYME Q10 IMPROVES LIPID PATTERN, ENDOTHELIAL REACTIVITY AND ARTERIAL STIFFNESS IN MODERATELY HYPERCHOLESTEROLEMICS (2016) (2)
- Cellular Ionic Composition at the Prehypertensive Phase of Essential Hypertension (1988) (2)
- Assessment of B-type natriuretic peptide (BNP) and n-terminal (NT)-probnp in hypertensive patients with heart failure (2004) (2)
- Hypersensitivity of gastric parietal cells to selective H2-receptor stimulation in duodenal ulcer. (1984) (2)
- How to avoid the depression of the adherence to antihypertensive treatment? (2013) (2)
- [Cardiovascular response to mental stress, dynamic and isometric exercise in a group of hypertensive patients treated with prizidilol (SK&F 92657)]. (1982) (2)
- REPRODUCIBILITY OF PRESSOR RESPONSE TO HANDGRIP: INFLUENCE OF TIME INTERVALS, STRENGTH AND DURATION OF EXERCISE (1987) (2)
- IDENTIFICATION OF THE CARDIOVASCULAR THRESHOLD LIMIT FOR SERUM URIC ACID. ANALYSIS FROM A GENERAL ITALIAN POPULATION (2019) (2)
- Management of a Multicomorbid Patient with Heart Failure (2017) (2)
- ACE Inhibitor and Renin–Angiotensin System the Cornerstone of Therapy for Systolic Heart Failure (2015) (2)
- Cost-effectiveness analysis of different hypertension management strategies (2019) (2)
- Management of High-Risk Hypercholesterolemic Patients and PCSK9 Inhibitors Reimbursement Policies: Data from a Cohort of Italian Hypercholesterolemic Outpatients (2022) (2)
- Effects of Telmisartan and Bisoprolol on Blood Pressure, Peripheral Haemodynamic and Lipid Profile in Statin-Treated Hypertensive Hypercholesterolaemic Patients (2009) (2)
- P-35: Effects of the combination of different doses of manidipine and delapril in hypertensive patients (2002) (2)
- AWARENESS OF MAJOR CARDIOVASCULAR RISK FACTORS AND ITS RELATIONSHIP WITH MARKERS OF VASCULAR AGING (2019) (2)
- Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) (2021) (2)
- People living with human immunodeficiency virus: Cardiovascular risk screening for an early and effective risk management. (2022) (2)
- Increased Serum Uric Acid as a Risk Factor for Cardiovascular Diseases (2013) (2)
- Prostatic tissue concentrations and serum levels of Myocamicin in human subjects. (1988) (2)
- Perception of emotions in borderline hypertensive patients and normal subjects. (1986) (2)
- Can peripheral arterial disease be early screened for in a podiatric setting? A preliminary study in a cohort of asymptomatic adults. (2012) (2)
- Rescue Therapies for Helicobacter pylori Infection in Foreign Patients Treated in Italy (2020) (2)
- Idiopathic sudden hearing loss: another kind of circulatory risk should not be neglected (2013) (2)
- Metabolic Aspects and Associated Risk Factors VITAMIN D SUPPLEMENTATION AND INCIDENT PREECLAMPSIA : FINDINGS FROM A SYSTEMATIC REVIEW AND META-ANALYSIS OF CONTROLLED CLINICAL STUDIES (2019) (2)
- Global Cardiovascular Disease Risk Management in Italian Patients with Metabolic Syndrome in the Clinical Practice Setting (2008) (2)
- Art as an asset class (2009) (2)
- Effects Phytosomal Curcumin On Anthropometric Parameters, Insulin-Resistance, Cortisolemia And Non-Alcoholic Fatty Liver Disease Indexes: A Double-Blind, Placebo-Controlled Clinical Trial (2019) (2)
- Hyperuricemia increases the risk of cardiovascular mortality associated with very high HdL-cholesterol level. (2022) (2)
- Characterization of a Na+/K+-ATPase inhibitor from human plasma: preliminary data. (1988) (2)
- Heart failure and chronic kidney disease in a registry of internal medicine wards (2014) (2)
- Gout, urate-lowering drugs, and risk of cardiovascular disease: can we clinically trust in the adjusted real-life data? (2021) (2)
- Association between aldosterone and parathyroid hormone levels in patients with adrenocortical tumors. (2021) (2)
- Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values (2022) (2)
- Successful treatment of a patient with mitochondrial myopathy with alirocumab. (2020) (2)
- Primary and secondary prevention of myocardial infarction. (1996) (2)
- Pharmacokinetics in Older Adults (2020) (2)
- LONG-TERM EFFECTS OF A BERBERINE BASED NUTRACEUTICAL ON BODY WEIGHT AND INSULIN-SENSITIVITY IN NON DIABETIC HYPERLIPIDAEMIC PATIENTS: PP.2.43 (2011) (2)
- Uric acid and thrombotic risk: an emerging link (2020) (2)
- 707-1 Short-term ACE-Inhibition and Onset and Progression of Congestive Heart Failure in Patients with Acute Myocardial Infarction (1995) (1)
- PCV121 A SURVEY OF PHYSICIANS' ATTITUDES TOWARD THE CONTROL OF CARDIOVASCULAR RISK FACTORS. THE EURIKA STUDY. (2010) (1)
- CHANGES IN LEVELS OF SERUM CHOLESTEROL AND DEVELOPMENT OF HYPERTENSION IN THE BRISIGHELLA HEART STUDY: 7B.05 (2010) (1)
- Changes in peripheral venous distensibility and blood pressure modifications in borderline hypertension: evidence against a primary role for the renin-angiotensin-aldosterone system. (1989) (1)
- Low doses of captopril in association with once-or twice-daily hydrochlorothiazide in essential hypertension: long-term efficacy and safety (1984) (1)
- Pathophysiology of cough with angiotensin-converting enzyme inhibitors: How to explain within-class differences? (2023) (1)
- Not all the eggs and the chickens are the same: The case of uric acid and metabolic syndrome. (2022) (1)
- Abnormal left ventricular structure and function in pregnancy complicated by pre-eclampsia (1998) (1)
- [PP.19.08] SERUM URIC ACID CHANGE AND MODIFICATION OF BLOOD PRESSURE AND FASTING PLASMA GLUCOSE IN A PHARMACOLOGICALLY UNTREATED POPOLATION SAMPLE: DATA FROM THE BRISIGHELLA HEART STUDY (2016) (1)
- Greater Pressor Reactivity in Women with Pre-Eclampsia is Not Related to Specific Psychological or Emotional Stressors (2010) (1)
- Uric acid and xantine-oxidase inhibitors in patients with gout: A re-assessment and an update. (2019) (1)
- Could statins exert a protective effect on epistaxis of systemic origin? (2011) (1)
- Metabolic alterations and hearing acuity: lack of a significant clinical correlation (2016) (1)
- Decrease mortality in type II diabetes mellitus: glycemic and renal function control (2018) (1)
- The attention on gender in studies on the treatment of hypertension : was it enough ? (2021) (1)
- Serum Uric Acid Predicts All-Cause and Cardiovascular Mortality Independently of Hypertriglyceridemia in Cardiometabolic Patients without Established CV Disease: A Sub-Analysis of the URic acid Right for heArt Health (URRAH) Study (2023) (1)
- Hypertension in children: Knowledge is the road to prevention. (2017) (1)
- Erratum to: Clinical Management of Hypertension in Pregnancy (2013) (1)
- Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register (2019) (1)
- Serum Malondialdehyde Levels in Hypertensive Patients: A Non-invasive Marker of Oxidative Stress. A Systematic Review and Meta-analysis (2022) (1)
- Ill-being and well-being in patients with masked hypertension: a controlled study. (2021) (1)
- Early management of hearing and balance disorders: a review of literature and a proposal to overcome possible uncertainties. (2010) (1)
- Sulphinpyrazone in Cardiovascular Elderly Azotemic Patients: A Proposal of a ‘Guided’ Incremental Dose Schedule (1984) (1)
- In response: Hyperuricemia as a risk factor for cardiovascular disease (2015) (1)
- Erratum to: Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized “Z” Studies (2017) (1)
- [25] HAEMODYNAMIC EFFECTS OF LACTOTRIPEPTIDES FROM FERMENTATION BY LACTOBACILLUS HELVETICUS IN NORMOTENSIVE SUBJECTS AND PATIENTS WITH HIGH-NORMAL BLOOD PRESSURE: A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER CLINICAL TRIAL (2009) (1)
- [Hypercholesterolemia as cardiovascular risk in hypertensive patients. Therapeutic implications: efficiency of statins]. (2003) (1)
- Update on Hypertension Management 2018 , 19 , nr . 69 URIC ACID AND HYPERTENSION : AN UPDATE (2018) (1)
- Cadralazine and chlorthalidone as a second-step drug with atenolol in hypertensive patients: Differences in blood pressure control during exercise (2004) (1)
- Who needs acetylsalicylic acid? Some order after many studies (2020) (1)
- Captopril Protects Against Metabolic Effects of Chronic Hydrochlorothiazide Therapy (1987) (1)
- Hypertension and hypercholesterolemia: from theory to cardiovascular disease risk prevention (2008) (1)
- Pharmacoeconomic considerations on the treatment of hypertension (2009) (1)
- Which statin is the ideal statin for polymedicated patients? (2012) (1)
- [PP.30.18] EFFECTS OF A COMBINED BLOOD PRESSURE AND LIPID-LOWERING NUTRACEUTICAL ON MILDLY HYPERTENSIVE HYPERCHOLESTEROLEMIC SUBJECTS: A PILOT, DOUBLE-BLIND, PLACEBO-CONTROLLED, RCT (2016) (1)
- Echocardiographic characteristics of hypertensive patients affected by transient ischemic attack: a cross-sectional study. (2017) (1)
- Tuesday, 28 August 2012 (2012) (1)
- Impact of anti-oestrogen therapy on lipoprotein(a) in postmenopausal women: a systematic review and meta-analysis of double-blind placebo-controlled clinical studies (2022) (1)
- Retrospective Analysis On Hospitalization And Health Care Costs, According To Serum Uric Acid Levels In Patients From A Sample Of Italian Local Health Units. (2014) (1)
- Uric acid, genetic scores and renal disease: merge to separate? (2022) (1)
- L’impiego di ezetimibe nella pratica clinica: dal laboratorio all’IMPROVE-IT (2015) (1)
- [ESC guidelines for treatment of cardiovascular disease in pregnancy]. (2012) (1)
- 1A.11: ASSOCIATION OF KIF6 AND HMGCR LOCI WITH CARDIOMETABOLIC PHENOTYPES AND RESPONSE TO STATIN THERAPY IN THE BRISIGHELLA COHORT (2015) (1)
- [LB.01.33] DRUG ADHERENCE AND CLINICAL OUTCOME IN RESPONSE TO PERINDOPRIL/AMLODIPINE FIXED DOSE COMBINATION IN AN ITALIAN CLINICAL PRACTICE SETTING. THE AMLODIPINE-PERINDOPRIL IN REAL SETTINGS (AMPERES) STUDY (2017) (1)
- RELATIONSHIP BETWEEN BLOOD PRESSURE AND LIPID PROFILE IN EUROPE.THE EURIKA STUDY: 7A.02 (2011) (1)
- F8 15-year development of stable hypertension in borderline hypertensives with abnormal pressor response to mental stress (1997) (1)
- Risk Factors for Lacunar Strokes with Visible Cerebral Lesions on Computed Tomography Scan. (2016) (1)
- Low dose of ACE-inhibitor enhances sodium excretion in volume expanded patients with borderline hypertension. (1996) (1)
- SAT0317 Correlation Between Serum Uric Acid and Left Ventricular Mass in Essential Hypertension (2015) (1)
- Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues—A Delphi Consensus Project (2022) (1)
- New evidences on the association between HDL-C and cardiovascular risk: a never ending research story. (2022) (1)
- P357 THE MANAGEMENT OF CHOLESTEROL LEVEL CONTROL WITH LIPID–LOWERING DRUGS IN ITALIAN CLINICAL PRACTICE: FINDINGS FROM THE STREAM (SUPPORTING WITH THE REAL–WORLD EVIDENCE THE ASSESSMENT OF MEDICINES AND HEALTH TECHNOLOGIES) STUDY (2022) (1)
- Socioeconomic status as determinant of individual cardiovascular risk. (2022) (1)
- EFFICACY AND SAFETY OF AN IRON CHELATING AGENT, DEFEROXAMINE, IN PATIENTS WITH RHEUMATOID ARTHRITIS AND HYPOSIDEREMIC ANEMIA (1990) (1)
- Effects of a combined nutraceutical on glucose and lipid metabolism in women with post-menopausal incident metabolic syndrome: a double-blind, placebocontrolled, randomized clinical trial (2019) (1)
- Projecting the long-term benefits of single pill combination therapy for patients with hypertension in five countries (2020) (1)
- Internal consistency of a new scale for the evaluation of benzodiazepine withdrawal syndrome (1994) (1)
- CAG and CRP Methodology - a Complement to AVO Calibration in Heterogeneous Medium (2001) (1)
- Febuxostat and atrial fibrillation. (2020) (1)
- Subjective effects of a combined lipid-lowering nutraceutical or ezetimibe on well-being and sexual performance in patients with perceived worsening of erectile function during statin treatment: a randomised clinical trial (2015) (1)
- Why one size doesn’t fit all – Case of Italy (2013) (1)
- Lipid-lowering treatment in patients at high cardiovascular risk discharged from an Italian hospital (2013) (1)
- Renin–angiotensin system modulation and outcomes in patients hospitalized for interstitial SARS-CoV2 pneumonia: a cohort study (2022) (1)
- Severe impaired blood pressure control caused by baroreflex failure as a late sequela of neck irradiation. (2019) (1)
- Early and late angiotensin-converting enzyme inhibition after myocardial infarction: an overview of randomized clinical trials. (2003) (1)
- SERUM URIC ACID, INDEPENDENTLY OF ARTERIAL HYPERTENSION, PREDICTS NON-FATAL INCIDENT CEREBROVASCULAR EVENTS IN AN ITALIAN LARGE COHORT OF MEN AND WOMEN. SEARCH FOR A CUT-OFF VALUE (2019) (1)
- FRI0337 Association Between Serum Uric Acid Levels and Cardiovascular Risk. A Post HOC Analysis of the European Cardiovascular Risk Patients: Disease Prevention and Management in Usual Daily Practice (Eurika) Study (2015) (1)
- P08.03: Post‐partum evaluation of maternal cardiac function in a cohort of severe pre‐eclamptic women (2012) (1)
- The VO(2)-on kinetics in constant load exercise sub-anaerobic threshold reflects endothelial function and dysfunction in muscle microcirculation. (2015) (1)
- Lipid-lowering drugs and blood pressure control in the brisighella heart study (2000) (1)
- [PP.03.07] PREDICTORS OF INCIDENT HYPERTENSION IN PREHYPERTENSIVES (2016) (1)
- Capsular Warning Syndrome: Features, Risk Profile, and Prognosis in a Large Prospective TIA Cohort (2022) (1)
- Cost effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post- hoc analysis of the smile-4 study (2013) (1)
- [BP.03.03] CARDIOVASCULAR RISK AND HYPERTENSION CONTROL IN ITALY. DATA FROM THE 2015 WORLD HYPERTENSION DAY (2017) (1)
- VO2 kinetics in supra-anaerobic threshold constant tests allow the visualization and quantification of the O2 saving after cytochrome c oxidase inhibition by aerobic training or nitrate administration. (2013) (1)
- Review for "Uric Acid Predicts Long-Term Cardiovascular Risk in Type 2 Diabetes but Does Not Mediate the Benefits of Fenofibrate: the FIELD Study" (2020) (1)
- [Ezetimibe in clinical practice: from laboratory investigations to the IMPROVE-IT trial results]. (2015) (1)
- [27] RISK PERCEPTION AND QUALITY OF LIFE IN CHILDREN WITH FAMILIAL HYPERLIPIDEMIAS AND THEIR PARENTS BEFORE AND AFTER LIFE-STYLE COUNSELING (2009) (1)
- ‘Use of lipid-lowering therapy: the guidelines, the drugs or the patient?’ (2022) (1)
- PCV30 PREVALENCE AND CONTROL OF TRADITIONAL CARDIOVASCULAR RISK FACTORS AND ANTICIPATED AVOIDABLE CORONARY MORTALITY IN PRIMARY PREVENTION IN EUROPE:THE EURIKA STUDY (2010) (1)
- The cost–effectiveness of irbesartan for hypertension (2015) (1)
- Cardiovascular response to mental stress: dynamic and isometric exercise in hypertensive patients treated with prizidilol hydrochloride (SK&F 92657). (1984) (1)
- Alarm reaction and serum K+ in hypertensive patients. (1990) (1)
- New Evidence about the Beneficial Effects of Angiotensin-Receptor Blockers on the Heart and the Kidney (2007) (0)
- [Activity of oral cefroxadin (Oraspor) in childhood infections. Multicentric study of 123 patients]. (1987) (0)
- [Hypertensive patients can benefit from a new generation of calcium channel blockers. Lercanidipine: effective with few side effects]. (2006) (0)
- [PP.25.18] EFFECT OF SPONTANEOUS CHANGES IN DIETARY COMPONENTS AND SERUM LIPOPROTEIN(A): DATA FROM THE BRISIGHELLA HEART STUDY (2017) (0)
- Ménière's disease: Is it time to approach it from another point of view? (2012) (0)
- PREVENTION AND TREATMENT OF BENZODIAZEPINE WITHDRAWAL: DOUBLE‐BLIND COMPARISON ALPIDEM VERSUS PLACEBO (1992) (0)
- LIPOPROTEIN (A) LEVELS PREDICT PULSE WAVE VELOCITY IN SUBJECTS IN PRIMARY PREVENTION FOR CARDIOVASCULAR DISEASE WITH LARGE APO(A) ISOFORMS: DATA FROM THE BRISIGHELLA HEART STUDY. (2022) (0)
- Effects of early Ace-inhibition in patients with acute myocardial infarction and metabolic syndrome. (2005) (0)
- Serum Proinflammatory Chemokines in Healthy Elderly Taking or not Taking Simvastatin - Data from the Brisighella Heart Study. (2014) (0)
- PP.LB02.10: CARDIOPROTECTIVE ROLE OF ZOFENOPRIL IN HYPERTENSIVES WITH ACUTE MYOCARDIAL INFARCTION A POOLED INDIVIDUAL DATA ANALYSIS OF FOUR RANDOMIZED, DOUBLE-BLIND, PROSPECTIVE STUDIES (2015) (0)
- PP.37.26: ASSOCIATION BETWEEN ARTERIAL STIFFNESS AND SELF-PERCEIVED SNORING AND SLEEP APNEA IN A LARGE COHORT OF PHARMACOLOGICAL UNTREATED SUBJECTS DATA FROM THE BRISIGHELLA HEART STUDY (2015) (0)
- PROGNOSTIC CUT-OFF VALUES OF SERUM URIC ACID ASSOCIATED WITH FATAL AND NON FATAL INCIDENT MYOCARDIAL INFARCTION INDEPENDENTLY OF ARTERIAL HYPERTENSION IN A LARGE COHORT (2019) (0)
- PO3-84 INFLUENCE OF METABOLIC SYNDROME SUPERPOSITION ON FAMILIAL COMBINED HYPERLIPOPROTEINEMIA CARDIOVASCULAR COMPLICATION RATE (2007) (0)
- P1566Identification of the cardiovascular threshold limit for serum uric acid. Analysis from a general Italian population (2019) (0)
- 59 ROLE OF LIPOPROTEIN(a) AND OTHER RISK FACTORS ON RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE (2008) (0)
- 2.11 Menopause and Blood Pressure: Results from Brisighella Heart Study (2007) (0)
- Cardiovascular risk in patients with metabolic syndrome enrolled in the Brisighella Heart Study. (2006) (0)
- Metabolic effects of anti-HCV direct acting antivirals (DAA): A retrospective study. (2017) (0)
- Black Garlic and Pomegranate Standardized Extracts for Blood Pressure Improvement: A Non-Randomized Diet-Controlled Study (2022) (0)
- [Pharmacologic treatment in elderly patients with heart failure. Which precautions?]. (1999) (0)
- Serum Uric Acid, Blood Pressure and Hypertension (2019) (0)
- PP.16.20: CORRELATIONS BETWEEN SERUM THIOCYANATES AND HEART RISK FACTORS IN THE HISTORICAL BRISIGHELLA HEART STUDY COHORT (2015) (0)
- Factors associated with acute salt-sensitivity in borderline hypertensive patients. (1992) (0)
- The association between blood pressure and lipid levels in Europe: EURIKA (2016) (0)
- National Cross-Sectional Survey on Blood Pressure: A Gateway to a Better Appraisal of Hypertension in the Young (2016) (0)
- D110 Safety aspects of calcium channel blockers in patients with hypertension associated with pregnancy. A retrospective survey (1997) (0)
- ItalianSocietyofRheumatology r ecommendationsforthemanagement ofgout (2013) (0)
- New Management Strategies for the Hypertensive Patient – from the Disease to the Patient (2007) (0)
- Zofenoprilof the Evidence of its Benefits in Hypertension and Acute Myocardial Infarction (2000) (0)
- Admission to the emergency care unit after faintness: patients' characteristics and paths (2012) (0)
- Temporal trend of antihypertensive drugs therapy and blood pressure control in the Brisighella Heart Study. (2004) (0)
- Left ventricular systolic and diastolic function and geometric patterns in elderly hypertensives (2005) (0)
- PCV101 - HYPERTRIGLYCERIDEMIA AND RISK OF ALL-CAUSE MORTALITY AND MAJOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) EVENTS IN CLINICAL PRACTICE: THE TG-REAL STUDY (2018) (0)
- Selected Abstracts from XXXVI National Congress of the Italian Society of Hypertension (SIIA), Rome, 26–28 September 2019 (2019) (0)
- P-41: Effects of pravastatin on blood pressure and vascular reactivity in borderline hypertensive subjects (2001) (0)
- Should diabetic blood pressure targets be the same in elderly compared with younger patients (2013) (0)
- P63 EFFECT OF HYPERCHOLESTEROLEMIA AND TREATMENT WITH STATINS ON THE ANTIHYPERTENSIVE EFFICACY TO OLMESARTAN AND AMLODIPINE: A RETROSPECTIVE CLINICAL TRIAL (2010) (0)
- ACE-inhibition role in the therapy of endothelial dysfunction related to arterial hypertension. (2010) (0)
- How to improve the cholesterol-lowering efficacy of ezetimibe in statin-intolerant patients in clinical practice: A retrospective study (2016) (0)
- CARDIOPROTECTIVE ROLE OF ACE-I IN PATIENTS WITH ACUTE MI: THE SMILE -OVERALL PROJECT (2012) (0)
- PP.27.21: CORRELATION BETWEEN SERUM URIC ACID AND LEFT VENTRICULAR MASS IN ESSENTIAL HYPERTENSION (2015) (0)
- THE IMPACT OF NEW BLOOD PRESSURE TARGETS IN CLINICAL PRACTICE (2019) (0)
- Prevalence of Tinnitus in a Population of Hypertensive Patients Referring to a Hypertensive Clinic: 2.10 (2005) (0)
- Erratum to: Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues (2016) (0)
- DOUBLE-BLIND, RANDOMIZED COMPARISON OF ZOFENOPRIL AND RAMPRIL IN PATIENTS WITH POST-MI LEFT VENTRICULAR DYSFUNCTION TREATED WITH ASA: THE SMILE IV STUDY (2011) (0)
- Physical Activity and Cardiovascular Disease Mortality: the BRISIGHELLA Heart Study (BHS) (2005) (0)
- Serum uric acid and left ventricular mass index independently predict cardiovascular mortality: The uric acid right for heart health (URRAH) project. (2023) (0)
- [OP.1B.02] SERUM URIC ACID AND BLOOD PRESSURE IN EUROPEAN RURAL POPULATION WITH NORMAL KIDNEY FUNCTION. DATA FROM BRISGHELLA HEART STUDY (ITALY) AND ENAH STUDY (CROATIA) (2016) (0)
- D34 Compliance to antihypertensive treatment. Relationships with clinical and psychological factors (1997) (0)
- Metabolic Syndrome and Hypertension: Brisighella Heart Study (BHS) (2005) (0)
- Zofenopril: Blood pressure control and cardio-protection (2021) (0)
- 5.15 Left Ventricular Patterns in a Population of a Hypertension Centre Echolab (2008) (0)
- Kidney Disease and Inner Ear Sufferance of Non-Familial Origin : A Review of the Literature and a Proposal of Explanation (2012) (0)
- 10.15 The Vasodilation at the Beginning of the Exercise in the Muscular Microcirculation is More Evident in the Repeated Exercise (2007) (0)
- SERUM URIC ACID LEVELS ARE ASSOCIATED WITH ASYMPTOMATIC PERIPHERAL ARTERY DISEASE (2019) (0)
- 32 BORDERLINE METABOLIC SYNDROME: NEW RISK FACTORS LEVELS TO KEEP AN EYE ON (2008) (0)
- P637 Evaluation of an innovative disease management model based on continuous interaction with congestive heart failure patients through teletransmission of data (2003) (0)
- Highlights from International Congress (2008) (0)
- Self-Reported Coffee Consumption and Central and Peripheral Blood Pressure in the Cohort of the Brisighella Heart Study (2023) (0)
- Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome. (2023) (0)
- Advances in pharmacotherapies for hyperuricemia (2023) (0)
- Clinical results and mechanism of action of icosapent ethyl (2023) (0)
- [26] EFFECT OF HYPERCHOLESTEROLEMIA AND TREATMENT WITH STATINS ON THE ANTIHYPERTENSIVE EFFICACY TO OLMESARTAN AND AMLODIPINE IN PATIENTS WITH HYPERTENSION AND DISLIPIDEMIA: A RETROSPECTIVE PILOT STUDY (2009) (0)
- [New therapeutic outlooks in the treatment of the hypertensive patient]. (1995) (0)
- [Evaluation of cardiovascular response to stress in dental patients]. (1990) (0)
- Comparison of the antihypertensive efficacy of two fixed-ratio combinations of captopril and hydrochlorothiazide (Capozide®, Squibb, S.p.a.) (1983) (0)
- Risk of cardiovascular mortality associated with very high HDL-cholesterol level and hyperuricemia in chronic kidney disease. (2023) (0)
- Acknowledgement to Referees (2018) (0)
- 7.10 Prevalence of Border-Line Metabolic Syndrome in Patients with Heart Failure (2007) (0)
- Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus (2022) (0)
- [28] ADIPOKINES AND SEX HORMONES ARE DIFFERENTLY ASSOCIATED TO CARDIOMETABOLIC RISK FACTORS IN A RANDOMIZED SAMPLE OF ADULT-ELDERLY HEALTHY SUBJECTS: THE BRISIGHELLA HEART STUDY (2009) (0)
- W22 QUALITY OF LIFE OF CHILDREN WITH FAMILIAL HYPERLIPIDEMIAS AFTER QUANTITATIVE OR QUALITATIVE DIETARY RESTRICTION (2010) (0)
- Statin therapy may protect against acute kidney injury in patients hospitalized for interstitial SARS-CoV2 pneumonia (2022) (0)
- D026: Effects of early ACE-inhibition in hypertensive patients with AMI (1998) (0)
- [PP.19.10] ISOLATED SYSTOLIC HYPERTENSION CHARACTERISTICS: DATA FROM THE BRISIGHELLA HEART STUDY (ITALY) AND THE ENAH STUDY (CROATIA) (2016) (0)
- Abstract: P1216 LIPOPROTEIN(A): A CAUSE OF RESTENOSIS AFTER INFRAINGUINAL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (2009) (0)
- Early ace-inhibition in patients with Q- and non-Q wave acute anterior myocardial infarction (1996) (0)
- 2009 SIPREC Consensus Document — Executive Summary (2010) (0)
- Estimation of Familial Combined Hyperlipoproteinemia Prevalence in a Large Rural Population: The Brisighella Heart Study (2007) (0)
- P14.09: PERIPHERAL ARTERIAL STIFFNESS ASSESSMENT FOR VASCULAR DISEASED PATIENTS: FEASIBILITY OF METHODS AND COMPARISON WITH CENTRAL PULSE WAVE VELOCITY PATIENTS: FEASIBILITY OF METHODS AND COMPARISON WITH CENTRAL PULSE WAVE VELOCITY, (0)
- Prognostic factors of benzodiazepine withdrawal syndrome during the first 28 days of benzodiazepine discontinuation (1993) (0)
- PO16-447 DETECTION OF FAMILIAL COMBINED HYPERLIPOPROTEINEMIA PATIENTS IN THE BRISIGHELLA HEART STUDY HISTORICAL COHORT: AN EPIDEMIOLOGICAL APPROACH (2007) (0)
- Role of Non Steroidal Anti-Inflammatory Drugs in the Instability of Clinical Picture of Patients with Heart Failure: 4.2 (2005) (0)
- Maternal Cardiac Evaluation During Uncomplicated Twin Pregnancy With Emphasis on the Diastolic Function (2016) (0)
- [Integrated approach to heart failure: a teaching and medical update model]. (1999) (0)
- A meta-analysis of Italian and Estonian individuals shows an effect of common variants in <italic>HMGCR</italic> on blood apoB levels (2019) (0)
- K023 Abnormal left ventricular structure and function in pregnancy complicated by pre-aclampsia (1998) (0)
- [PP.25.39] NUTRACEUTICAL EFFECTS ON GLUCOSE AND LIPID METABOLISM IN PATIENTS WITH IMPAIRED FASTING GLUCOSE: A PILOT, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL (2017) (0)
- Hydroxytyrosol-Rich Olive Extract for Plasma Cholesterol Control (2022) (0)
- [Epidemiologic and socioeconomic impact of heart failure]. (1999) (0)
- SERUM URIC ACID, INDEPENDENTLY OF ARTERIAL HYPERTENSION, PREDICTS FATAL HEART FAILURE IN A LARGE COHORT OF MEN AND WOMEN. SEARCH FOR A CUT-OFF VALUE (2019) (0)
- [Comparison of the antihypertensive effectiveness of captopril in combination with various doses of hydrochlorothiazide]. (1988) (0)
- [The Symplicity HTN-2 study]. (2011) (0)
- Systemic broad-spectrum antimicrobial prophylaxis in hematological patients after intensive antineoplastic chemotherapy. (1990) (0)
- [2] PREVALENCE OF PERIPHERAL ARTERIAL DISEASE IN SUBJECTS AT MODERATE CARDIOVASCULAR RISK. ITALIAN RESULTS OF THE PANDORA STUDY (2009) (0)
- Machine Learning in Hypertension Detection: A Study on World Hypertension Day Data (2022) (0)
- AB0216 Activation of the renin angiotensin sistem in a population of patients with rheumatoid arthritis and low severity comorbidity in therapy with dmards and/or anti-tnf alfha (2013) (0)
- URIC ACID AND CARDIOMETABOLIC DISEASE: FROM BENCH TO BEDSIDE (2018) (0)
- Correction: Cicero et al. Long-Term Impact of Different Triple Combination Antihypertensive Medications on Blood Pressure Control, Metabolic Pattern and Incident Events: Data from the Brisighella Heart Study. J. Clin. Med. 2021, 10, 5921 (2022) (0)
- Three-arm, placebo controlled, randomized clinical trial evaluating the metabolic effect of a bergamot standardized flavonoid extract in dyslipidemic overweight subjects. (2019) (0)
- [OP.7B.06] METABOLIC SYNDROME IN EUROPEAN RURAL POPULATION- DATA FROM THE BRISGHELLA HEART STUDY (ITALY) AND ENAH STUDY (CROATIA) (2016) (0)
- PP.LB01.04: A NEW METHOD TO MEASURE THE SHORT TERM BLOOD PRESSURE VARIABILITY (2015) (0)
- Cardiovascular drugs and mortality in hypertensive patients with atrial fibrillation: evidence of efficacy for a global approach (2014) (0)
- PP.07.27: LIPID-LOWERING AND ANTI-INFLAMMATORY EFFECTS OF OMEGA 3 ETHYL ESTERS AND KRILL OIL A RANDOMIZED, CROSS-OVER, CLINICAL TRIAL (2015) (0)
- Portrait of the Countess Anastasia Spini (1842): acromegaly in art (2019) (0)
- Halometasone/triclosan cream: (Sicorten plus). A study of clinical and allergological behaviour (1987) (0)
- Pulse pressure and cardiovascular mortality. Results of a large italian population survey (1999) (0)
- S-17-1: URIC ACID AND CARDIOVASCULAR DISEASES (2023) (0)
- 2017 Reviewer Acknowledgment (2018) (0)
- Prevalence and incidence of atrial fibrillation in a large cohort of adrenal incidentalomas: A long-term retrospective study (2020) (0)
- LONG-TERM EFFICACY AND SAFETY OF A COMBINED NUTRACEUTICAL ADDED TO THERAPEUTIC LIFE-STYLE IN OVERWEIGHT AND NORMOWEIGHT DYSLIPIDAEMIC SUBJECTS: A CONTROLLED TRIAL: PP.2.47 (2011) (0)
- EFFECT OF QUANTITATIVE AND QUALITATIVE DIET PRESCRIPTION ON CHILDREN BEHAVIOUR AFTER A DIAGNOSIS OF FAMILIAL DYSLIPIDEMIA (2018) (0)
- FROM GOUT TO CARDIOVASCULAR DISEASE: A CENTRAL ROLE FOR URIC ACID (2014) (0)
- Nephrotic range proteinuria and acute heart failure (2019) (0)
- Relationship between intralymphocytic sodium content and pressor response to mental arithmetic and static exercise in essential hypertension. (1983) (0)
- Impact of simultaneous management of hypertension and hypercholesterolemia with ACE inhibitors and statins on cardiovascular outcomes in the Brisighella Heart Study: A 8-year follow-up. (2022) (0)
- EFFECT OF AN INTEGRATED APPROACH TO CARE ON HEART FAILURE PATIENTS WITH HYPERTENSION: PP.1.11 (2010) (0)
- THU0420 Improved survival of post-myocardial infarction patients treated with zofenopril combined with xantine oxidase inhibitors as compared to placebo or other ace-i (2017) (0)
- PP.41.18: ASSOCIATION BETWEEN SERUM URIC ACID LEVELS AND CEREBRAL SMALL VESSEL DISEASE IN ELDERLY SUBJECTS (2015) (0)
- [Hypercholesterolemia: facts, myths and advances]. (2016) (0)
- Xanthine oxidase inhibition and cardiovascular protection: Don't shoot in the dark. (2023) (0)
- Selected Abstracts from the National Congress of the Italian Society of Hypertension (SIIA 2009): 2009 October 1–4, Rome, Italy (2012) (0)
- [Uncertainties in cardiovascular risk factors: sodium-glucose cotransporter 2 inhibitors for all diabetic patients with high cardiovascular risk and in all patients with renal insufficiency, regardless of albuminuria? Glucagon-like peptide-1 receptor agonists as a weapon against obesity?] (2023) (0)
- Zofenopril is a cost-effective treatment for patients with left ventricular systolic dysfunction following acute myocardial infarction: a pharmacoeconomic analysis of the SMILE-4 study (2013) (0)
- Prevalence of tinnitus in a population of hypertensive patients reffering to a hypertensive clinic. (2005) (0)
- A possible mechanism to explain how ischaemia and the maintained function of gastric type proton pumps could lead to hydrops of the inner ear in Ménière's disease (2013) (0)
- G043: Pulse pressure (PP) and cardiovascular disease, is PP an independent risk factor? Results from the Brisighella Heart Study (BHS) (2000) (0)
- [PP.03.11] PREHYPERTENSION IS ASSOCIATED WITH CHRONIC KIDNEY DISEASE IN EUROPEAN RURAL POPULATION- DATA FROM BRISGHELA HEART STUDY (ITALY) AND ENAH STUDY (CROATIA) (2016) (0)
- [Definition of acute heart failure]. (2014) (0)
- Sudden Fall in the Lipid-Lowering Effect of Evolocumab: The Butler Is Not Always Guilty (2021) (0)
- SaO018THE RELATIONSHIP BETWEEN SERUM URIC ACID AND ALL-CAUSE MORTALITY: SYSTEMATIC REVIEW AND META-ANALYSIS OF 3,034,994 PARTICIPANTS (2019) (0)
- Natural mutations of human XDH promote the nitrite (NO2-)-reductase capacity of xanthine oxidoreductase: a novel mechanism to promote redox health? (2023) (0)
- We-P13:358 Hypertension and metabolic sindrome in the Brisighella Study (BS) (2006) (0)
- Temporal trend of antihypertensive drugs therapy and blood pressure control in the brisighella heart study (2004) (0)
- L20. Differences in the hemodynamic profile between pre-eclampsia and other forms of hypertension in pregnancy. (2011) (0)
- [Evaluation of the efficacy of a single daily administration of slow-release diclofenac in the treatment of degenerative and non-degenerative arthropathies. Multicenter study concerning 643 patients]. (1984) (0)
- PULSE WAVE VELOCITY IN YOUNG PEOPLE: ROLE OF BIRTH WEIGHT, POSTNATAL GROWTH, LIFESTYLE, ANTHROPOMETRIC AND HEMODYNAMIC PARAMETERS: 9B.06 (2011) (0)
- Sudden Fall in the Lipid-Lowering Effect of Evolocumab: The Butler Is Not Always Guilty (2021) (0)
- Update in uric acid, hypertension, and cardiovascular diseases. (2023) (0)
- Non-invasive instrumental evaluation of coenzyme Q10 phytosome on endothelial reactivity in healthy non-smoking young volunteers: a double-blind, placebo-controlled cross-over clinical trial (2022) (0)
- Abstract 9207: Zofenopril and Ramipril Plus ASA in Post-myocardial Infarction Patients With Left Ventricular Systolic Dysfunction: A Post-hoc Analysis in Preserved or Impaired Left Ventricular Fraction at Entry (2012) (0)
- [OP.1A.10] CIRCULATING LEVELS OF PCSK9 AND ARTERIAL STIFFNESS IN A LARGE POPULATION SAMPLE: DATA FROM THE BRISIGHELLA HEART STUDY (2017) (0)
- A subgroup analysis of the ODYSSEY APPRISE study: Safety and efficacy of alirocumab in the Italian cohort. (2022) (0)
- 966-42 Pressor Reactivity to Stress and Development of Stable Hypertension in Borderline Hypertensives (1995) (0)
- Relationship between serum cholesterol levels and development of arterial hypertension in the population of the brisighella heart study (2003) (0)
- 03 - THREE-ARM, PLACEBO CONTROLLED, RANDOMIZED CLINICAL TRIAL EVALUATING THE METABOLIC EFFECT OF A BERGAMOT STANDARDIZED FLAVONOID EXTRACT IN DYSLIPIDEMIC OVERWEIGHT SUBJECTS. (2019) (0)
- The Brisighella Heart Study: cardiovascular complications in subjects in subjects with metabolic syndrome. (2006) (0)
- Efficacy of Zofenopril Alone or in Combination with Hydrochlorothiazide in Patients with Kidney Dysfunction. (2019) (0)
- Effects of different dosages of hydrochlorothiazide on blood pressure and the renin-angiotensin-aldosterone system in mild to moderate essential hypertension (1992) (0)
- 25 LONG-TERM EFFECTIVENESS AND SAFETY OF A NUTRACEUTICAL BASED APPROACH TO REDUCE CHOLESTEROLEMIA IN STATIN INTOLERANT SUBJECTS WITH AND WITHOUT METABOLIC SYNDROME (2008) (0)
- Algorithm for Mobile Platform-Based Real-Time QRS Detection (2023) (0)
- 2.21 Integrated Out-Patient Management of Hypertensive Patients with Heart Failure: Effects on NYHA Class and Ejection Fraction in Patient with Compromised and Preserved Systolic Function (2007) (0)
- Reply to: Serum uric acid levels positively correlates with 10-year cardiovascular risk score in the general population from China. (2018) (0)
- 564 ZOFENOPRIL AND RAMIPRIL PLUS ASA IN POST- MYOCARDIAL INFARCTION PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION: A POST-HOC ANALYSIS IN PATIENTS WITH ARTERIAL HYPERTENSION (2012) (0)
- Estimating the burden of hyperlipidemia in a hypertensive ambulatory population (2006) (0)
- SEX HORMONES AND ADIPOKINES IN HEALTHY PRE-MENOPAUSAL, POST-MENOPAUSAL AND ELDERLY WOMEN, AND IN AGE-MATCHED MEN: DATA FROM THE BRISIGHELLA HEART STUDY: PP.34.374 (2010) (0)
- Erratum to: National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities (2014) (0)
- IMPACT OF COMBINED TREATMENT WITH ACE INHIBITORS AND STATINS ON CARDIOVASCULAR OUTCOMES IN THE BRISIGHELLA HEART STUDY: A 8-YEAR FOLLOW-UP (2022) (0)
- Is it possible to consider non-conventional proposals for treating Ménière's disease? (2012) (0)
- Gender specific haemodinamic and metabolic effects of a sequential training program on hypertensive overweight patients. (2009) (0)
- Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study (2018) (0)
- PP.41.19: RELATIONSHIP BETWEEN SERUM URIC ACID AND METABOLIC SYNDROME IN THE BRISIGHELLA HEART STUDY COHORT (2015) (0)
- URIC ACID IS ASSOCIATED WITH CARDIOMETABOLIC RISK FACTORS IN OVERWEIGHT AND OBESE CHILDREN AND ADOLESCENTS (2018) (0)
- Tailoring treatment to comorbidities (2019) (0)
- P-120: Compliance of antihypertensive treatment and monotherapy. Behaviour of the calcium-channel blocker lercanidipine (2005) (0)
- Cefroxadine in the treatment of various bacterial infections (1988) (0)
- Serum uric acid and blood pressure in an European rural population with normal kidney function. Data from the Brisighella heart study (Italy) and ENAH study (Croatia) (2017) (0)
- 101P Ejection fraction does not reflect different patterns of left ventricular remodelling in a 3-month post-myocardial infarction trial (1994) (0)
- P-323: Cholesterol levels, plasma renin activity and incidence of stable hypertension in young subjects with high-normal blood pressure (2004) (0)
- Wednesday, 29 August 2012 (2012) (0)
- [Integration of therapeutic options and the candidates for treatment: the ABC of the post-infarction period]. (1996) (0)
- A meta-analysis of Italian and Estonian individuals shows an effect of common variants in HMGCR on blood apoB levels. (2019) (0)
- THE USE OF β-BLOCKERS IN HYPERTENSION (2011) (0)
- Effectiveness of first and second‐line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management (2022) (0)
- P-129: Effects of an integrated approach to care in the management of hypertensive patients with heart failure (2003) (0)
- [Orthostatic hypotension and supine hypertension: a parctical guide to diagnosis and management]. (2021) (0)
- P-407: Left ventricular structure and function and development of pregnancy-related hypertensive disorders in pregnant women with altered utero-placental flow (2005) (0)
- Evaluation of the short term efficacy and tolerability of a combined nutraceutical with lipid-lowering properties: a randomized clinical trial (2011) (0)
- PREDICTORS OF CARDIOVASCULAR RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS (2019) (0)
- PP.42.03: RELATIONSHIP BETWEEN SERUM URIC ACID AND CARDIOVASCULAR PHENOTYPES IN THE BRISIGHELLA COHORT A MENDELIAN RANDOMIZATION ANALYSIS (2015) (0)
- Hypertension and hypercholesterolemia: from theory to cardiovascular disease risk prevention. Second edition (2009) (0)
- Reply to 'The uric acid value of 4.8 mg/dl may not be an ideal prognostic threshold for cardiovascular disease mortality'. (2022) (0)
- Letter by Cicero et al Regarding Article, "Long-Term Excessive Body Weight and Adult Left Ventricular Hypertrophy Are Linked Through Later-Life Body Size and Blood Pressure: The Bogalusa Heart Study". (2017) (0)
- HIGH PREVALENCE OF UNDIAGNOSED HYPERTENSION IN YOUNG MALE SUBJECTS: DATA FROM THE BRISIGHELLA HEART STUDY: PP.16.21 (2011) (0)
- Correction: Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension (2021) (0)
- Is it time to implement a standardized oral glucose and fat load test to detect high risk patients? Probably not yet…. (2015) (0)
- SERUM URIC ACID, LEFT VENTRICULAR MASS AND CARDIOVASCULAR DEATH. THE URIC ACID RIGHT FOR HEART HEALTH (URRAH) STUDY (2022) (0)
- PO11-311 MMP-2, MMP-9 AND THEIR INHIBITORS AND OTHER PROTHROMBOTIC RISK FACTORS PLASMA LEVEL IN FCH, MS, FCH+MS AND CONTROL SUBJECTS (2007) (0)
- P-532: Left ventricular hypertrophy in a potential donors population (2001) (0)
- PULSE PRESSURE IS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR EVENTS – BRISIGHELLA HEART STUDY (BHS): P3.98 (2000) (0)
- Focus on arterial stiffness (2017) (0)
- P-130: Constant load exercise VO2 kinetics study in the evaluation of heart failure (2003) (0)
- Invited review Pharmacoeconomic considerations on the treatment of hypertension (2009) (0)
- Treatment of acute anterior myocardial infarction with zofenopril (1995) (0)
- P-401: Histological assessment of renal damage in high or low cardiovascular risk profile potential organ donors (2002) (0)
- Nutrients and Nutraceuticals for the Management of High Normal Blood Pressure: An Evidence‑Based Consensus Document (2019) (0)
- Correlation between arterial blood pressure and metabolic risk factors in the elderly population: The Brisighella Study (1999) (0)
- 855 Effect of an integrated approach to care on heart failure patients with hypertension (2007) (0)
- ALPIDEM, A NEW ANXIOLYTIC FOR TREATING AND PREVENTING BENZODIAZEPINE WITHDRAWAL SYNDROME: A DOUBLE-BLIND PLACEBO CONTROLLED STUDY (1994) (0)
- Not all that trembles…: a rare case of extrapyramidal impairment (2019) (0)
- 483 PREVALENCE OF ELEVATED C-REACTIVE PROTEIN LEVELS IN A PRIMARY CVD PREVENTION POPULATION IN EUROPE: THE EURIKA STUDY (2011) (0)
- The Normalization of the Indexes of Reno-Vascular Resistance as an Effect of the Renal Protection Induced by Losartan in Patients with Arterial Hypertension after 5 Years of Treatment: 5.24 (2005) (0)
- Iron deficiency correction in heart failure patients with preserved ejection fraction: a case series study (2021) (0)
- Le implicazioni per la pratica clinica dello studio ADVANCE. (2008) (0)
- [Simultaneous determination of pressor and peripheral vascular response to isometric exercise. Reassessment of the methodology]. (1988) (0)
- Mo-P1:102 High-density lipoprotein and risk of cardiovascular events: A clinical investigation in a sample of adults from the Brisighella heart study cohort (2006) (0)
- Interaction between lipid abnormalities and hypertension: the role of the renin-angiotensin system. (2008) (0)
- CO –05 - Relative role of major risk factors for impaired fasting glycaemia development in the historical cohort of the Brisighella Heart Study: a 12-year follow-up (2013) (0)
- How cardiologists can manage excess body weight and related cardiovascular risk. An expert opinion. (2023) (0)
- ACE-INHIBITORS AND CARDIOPROTECTION OPEN ISSUES AND FUTURE SOLUTIONS Summary of Presentations from the Menarini Symposium , ESC Annual Congress 2013 , Amsterdam , the Netherlands Chairperson (2013) (0)
- Angina in a diabetic patient: a case of integrated approach (2008) (0)
- Long-term impact of different triple antihypertensive drug treatments on blood pressure control, metabolic pattern and incident events: data from the Brisighella Heart Study (2022) (0)
- [Renal tolerance of an incremental dosage regimen of anturan in the aged with altered renal function]]. (1985) (0)
- The UrgeRe (Urgenze Ipertensive: Un Progetto Educazionale Fondato Sulla Vita Reale, Hypertensive Urgencies: A Project in the Real World) Project (2021) (0)
- P62 HAEMODYNAMIC EFFECTS OF LACTOTRIPEPTIDES FROM CASEIN HYDROLYSATE IN MEDITERRANEAN HEALTHY SUBJECTS: A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER TRIAL (2010) (0)
- Manidipine of its Use in the Management of Hypertension (2004) (0)
- Work-related cardiovascular stress in orthodontists: A pilot project (2016) (0)
- 27 METABOLIC EFFECT OF A SEQUENTIAL TRAINING PROGRAM ON HYPERTENSIVE OVERWEIGHT PATIENTS WITH AND WITHOUT METABOLIC SYNDROME (2008) (0)
- Abstract: P1300 BORDERLINE METABOLIC SYNDROME: NEW RISK FACTORS LEVELS (2009) (0)
- NON-INVASIVE INSTRUMENTAL EVALUATION OF COENZYME Q10 PHYTOSOME ON ENDOTHELIAL REACTIVITY IN HEALTHY NON-SMOKING YOUNG VOLUNTEERS: A RANDOMIZED, PLACEBO-CONTROLLED CROSS-OVER STUDY (2022) (0)
- Effects of early ACE-inhibition in patients with AMI and arterial hypertension (1998) (0)
- ECHOCARDIOGRAPHY IN PATIENTS WITH HEART FAILURE: REDUCED AND PRESERVED LEFT VENTRICULAR FUNCTION: PP.1.14 (2010) (0)
- A case of liver injury during lipid‐lowering therapy (2022) (0)
- Salt intake, intracellular cations, and hypertension. (1986) (0)
- Effects of pharmacological modulation of the renin‐angiotensin‐aldosterone system on salt sensitivity in patients with borderline hypertension (1993) (0)
- Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both (2023) (0)
- The normalization of reno-vascular resistance index as a consequence of renal protection induced by losartan in patients with arterial hypertension after 5 years of treatment. (2005) (0)
- is double-blinding possible while administering fluids in the intensive care unit? (2013) (0)
- Erratum: National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities [High Blood Press Cardiovasc Prev, (2014), 21, (29-36), DOI 10.1007/s40292-013-0034-z] (2015) (0)
- Pulse pressure amplification, pressure waveform calibration and target organ damage (2011) (0)
- Prevalence of Border-Line Metabolic Syndrome in Patients with Heart Failure (2007) (0)
- ヨーロッパ心血管疾患の一次予防における血圧コントロールの欠如:ヨーロッパ心血管イベントリスクの日常的予防と管理研究結果【JST・京大機械翻訳】 (2016) (0)
- Cardiovascular diseases and risk factors: is it time to move forward? (2012) (0)
- Circulating levels of PCSK9 and arterial stiffness in a large population sample: Data from the brisighella heart study. (2017) (0)
- AUTOMATED OFFICE BLOOD PRESSURE (AOBP) IS LOWER THAN OFFICE BLOOD PRESSURE (OBP) BUT HOW IT COMPARES WITH AMBULATORY BLOOD PRESSURE MEASURES (ABPM)? (2018) (0)
- Pressor response to stress and incidence of stable hypertension in borderline hypertensives. (1995) (0)
- BLOOD PRESSURE AND METABOLIC EFFECTS OF A COMBINATION OF LERCANIDIPINE WITH DIFFERENT ANTIHYPERTENSIVE DRUGS IN CLINICAL PRACTICE: PP.5.176 (2010) (0)
- P-307: Blood pressure control and temporal trend of antihypertensive drugs therapy in the Brisighella Heart Study (2002) (0)
- Lercanidipine and hypertension treatment: a review. (2004) (0)
- [Antihypertensive efficacy and effects on intra and extracellular electrolytes of a canrenoate potassium-butizide combination]. (1988) (0)
- Sulphinpyrazone dose schedule in hyperuricemic patients with cardiovascular diseases: tolerability assessment. (1985) (0)
- A possible role for hydrochlorothiazide (HCTZ) as "enhancer" of zofenopril activity at the tissue level (2013) (0)
- Inner ear dysfunction: the role of non-audiological factors. (2008) (0)
- Efficacy of Ace Inhibition with Zofenopril, Lisinopril, or Ramipril in Postacute Myocardial Infarction Patients With or Without Metabolic Syndrome: A Pooled Individual Data Analysis of Four Randomized, Double-Blind, Controlled, Prospective Studies (2017) (0)
- Serum lipoprotein(a) levels and dietary micro/macronutrients: Data from the Brisighella Heart Study (2017) (0)
- Adjusted neck circumference and metabolic syndrome: Results from the brisighella heart study (2016) (0)
- 52. Sympathetic and cardiovascular reactivity during mental stress in patients with essential hypertension (2016) (0)
- INFLUENCE OF LIPOPROTEIN(A) ON RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE (PAD) (2008) (0)
- PRIMARY AND SECONDARY PREVENTION OF MYOCARDIAL f NFARCTION (1996) (0)
- P-265: Prevalence of tinnitus in a population of hypertensive patients referring to a hypertensive clinic (2005) (0)
- May Measurement Month: results of 12 national blood pressure screening programmes between 2017 and 2019 (2022) (0)
- Letter by Del Pinto et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)". (2018) (0)
- Cardioprotective role of zofenopril in patients with acute myocardial infarction: high-risk subgroup analysis of the SMILE OVERALL project (2013) (0)
- Pharmacoeconomic approch to the treatment of hypertension: from clinical trials to clinical practice. (2005) (0)
- Arterial Hypertension and Risk of Stroke and Myocardial Infarction (1992) (0)
- Role of global cardiovascular risk in patients with rheumatoid arthritis. (2006) (0)
- Pulse pressure and cardiovascular mortality in normotensive borderline and hypertensive subjects. Results of a Brisighella Heart Study. (1999) (0)
- Pulse wave velocity and diabetes duration in type 2 diabetes mellitus (2013) (0)
- Are monotherapies still valuable to the treatment of hypertension? (2020) (0)
- Reply. (2020) (0)
- PP.LB03.05: IMPACT OF AGEING AND CARDIOVASCULAR RISK FACTORS ON VENTRICULAR REPOLARIZATION STUDIED WITH STANDARD ECG (2015) (0)
- C4. Maternal cardiac changes during uncomplicated twin pregnancy: does the chorionicity matter? (2016) (0)
- 7.6 Brisighella Heart Study: Metabolic Syndrome and Uricaemia (2007) (0)
- Effects of lactotripeptides assumed as functional food on office and 24-hour blood pressure, stress-induced blood pressure increase, pulse wave velocity and cardiac output related parameters: a rondomized, double-blindd, clinical trial. (2010) (0)
- Abstract 9850: Cardioprotective Role of Zofenopril in Hypertensive Patients With Acute Myocardial Infarction: A Pooled Individual Data Analysis of Four Randomized, Double-blind, Controlled, Prospective Studies (2015) (0)
- Effects of non steroidal anti-inflammatory drugs on clinical aspects and blood pressure in patients with heart failure. (2005) (0)
- 1.5 Brisighella Heart Study: Hypertension, HDL Cholesterol and Triglycerides (2008) (0)
- CARDIOVASCULAR DISEASE RISK PERCEPTION IN PATIENTS AFFECTED BY FAMILIAL HYPERLIPIDAEMIAS IN SPECIALIST SETTING (2008) (0)
- Cardioprotective role of zofenopril in hypertensive patients with acute myocardial infarction: a pooled individual data analysis of the SMILE studies (2017) (0)
- AJG-21-1347 147..157 (0)
- Council ' s Corner : Hypertension Issues-a personal view (2017) (0)
- Purine Metabolism Dysfunctions: Experimental Methods of Detection and Diagnostic Potential (2023) (0)
- EFFECT OF A COMBINED NUTRACEUTICAL ADDED TO THERAPEUTIC LIFE-STYLE ON BIOMARKERS OF VASCULAR REMODELLING IN OVERWEIGHT AND NORMOWEIGHT DYSLIPIDAEMIC SUBJECTS: A CONTROLLED TRIAL: PP.2.48 (2011) (0)
- [PP.22.16] APPLE POLIPHENOLS EFFECTS ON ENDOTHELIAL REACTIVITY AND SERUM URIC ACID: FROM PRECLINICAL DATA TO A DOUBLE BLIND-RANDOMIZED CLINICAL TRIAL (2017) (0)
- ' s response to reviews Title : Prevalence of peripheral arterial disease in subjects with moderate cardiovascular risk : Italian results from the PANDORA study (2011) (0)
- 7.5 Brisighella Heart Study: Metabolic Syndrome and Predictive Factors (2007) (0)
- Assessment of B-type natriuretic peptide (BNP) and N-terminal (NT)-probnp in patients with heart failure of hypertensive or not hypertensive origin (2004) (0)
- Short-term evolocumab-induced tendon xanthomas regression in an elderly patient with homozygous familial hypercholesterolemia (2022) (0)
- [OP.LB03.08] EFFECTS OF LTP2 PEPTIDE RICH WHEAT PRODUCTS ON BLOOD PRESSURE, ENDOTHELIAL REACTIVITY AND OTHER CARDIOVASCULAR RISK FACTORS: A DOUBLE-BLIND, CROSS-OVER, RANDOMIZED CLINICAL TRIAL (2016) (0)
- [51] METABOLIC SYNDROME, TYPE II DIABETES AND NON FATAL CARDIOVASCULAR EVENTS IN BRISIGHELLA HEART STUDY (2009) (0)
- THE TOTAL CARDIOVASCULAR RISK (2008) (0)
- AN EASY STRATEGY TO MANAGE NIGHT CRAMPS ASSOCIATED TO STATIN ASSUMPTION: RESULTS FROM A REAL PRACTICE STUDY (2018) (0)
- ANTIHYPERTENSIVE EFFECT OF LACTOTRIPEPTIDES IN A LARGE COHORT OF NORMOTENSIVE AND MILDLY-TO-MODERATELY HYPERTENSIVE SUBJECTS: A DOUBLE-BLIND, RANDOMIZED, CLINICAL TRIAL: 2C.04 (2011) (0)
- LONG-TERM EFFECT OF DIFFERENT TRIPLE COMBINATION ANTIHYPER-TENSIVE MEDICATIONS: DATA FROM THE BRISIGHELLA HEART STUDY (2022) (0)
- From classical to innovative clinical epidemiology: the 50 years' experience of the Brisighella Heart Study. (2021) (0)
- BLOOD PRESSURE INDEPENDENT EFFECTS OF LOSARTAN AND CHLORTALIDONE ON RENO-VASCULAR RESISTANCE IN NON-DIABETIC PATIENTS WITH ESSENTIAL HYPERTENSION: 4B.4 (2004) (0)
- Selective Peroxisome Proliferator-Activated Receptor-γ Modulation in the Treatment of Hypertension and Metabolic Syndrome (2006) (0)
- Hypertriglyceridemia is associated with decline of estimated glomerular filtration rate and risk of end-stage kidney disease in a real-word Italian cohort: Evidence from the TG-RENAL Study. (2023) (0)
- Effects of Intravenous Fructose Infusion on Sodium Handling and Peripheral Vascular Tone in Pre-Hypertensive Subjects (1994) (0)
- Acknowledgment to Reviewers (2020) (0)
- Mo-P1:24 Brisighella heart study: Metabolic syndrome in a borderline area (2006) (0)
- 29 EFFECT OF PHYSICAL ACTIVITY ON VASCULAR REMODELLING BIOMARKERS IN HYPERTENSIVE OVERWEIGHT PATIENTS (2008) (0)
- [New evidence on coffee consumption, hypertension and cardiovascular diseases]. (2022) (0)
- Role of Some Individual Factors in the Effect of Statins on Blood Pressure Control in Hypertensive Patients: 2.4 (2005) (0)
- ALLOPURINOL AND FEBUXOSTAT EFFECT ON TOTAL MORTALITY IN HYPERURICEMIC PATIENTS AFFECTED BY MILD-TO-MODERATE HEART FAILURE (2018) (0)
- Clinical benefits of low frequency respiratory pacing in heart failure patients (2003) (0)
- TRIGLYCERIDES-GLUCOSE INDEX: A NEW PREDICTOR OF INCREASED ARTERIAL STIFFNESS. RESULTS FROM SEPHAR III – BRISIGHELLA HEART STUDY POOLING PROJECT (2018) (0)
- PP.LB02.09: ZOFENOPRIL OR RAMIPRIL COMBINED WITH ASA IN THE EARLY TREATMENT OF ACUTE MYOCARDIAL INFARCTION ASSOCIATED WITH LEFT VENTRICULAR DYSFUNCTION. 5-YEAR FOLLOW-UP OF THE SMILE-4 (2015) (0)
- Validation of A New Non-invasive Tonometer for Determining Aortic Pulse Wave Velocity in Rats (2010) (0)
- Adherence to Triple Single-Pill Combination of Perindopril/Indapamide/Amlodipine: Findings from Real-World Analysis in Italy (2023) (0)
- INTERACTION BETWEEN LDL-CHOLESTEROLEMIA, SERUM URIC LEVEL AND INCIDENT HYPERTENSION: DATA FROM THE BRISIGHELLA HEART STUDY (2018) (0)
- PS-BPC07-5: A REAL-WORLD ANALYSIS OF PHARMACO-UTILIZATION AND OUTCOMES OF PATIENTS ON PERINDOPRIL/AMLODIPINE/INDAPAMIDE FREE VS SINGLE-PILL COMBINATION IN ITALY (2023) (0)
- Prognostic value of serum lipoprotein(a) levels on long-term mortality in a large sample of subjects in primary cardiovascular prevention: Data from the Brisighella Heart Study (2016) (0)
- IS GENDER SUFFICIENTLY TAKEN INTO CONSIDERATION BY SCIENTIFIC STUDIES ON HYPERTENSION? (2019) (0)
- P358 THE ROLE OF ADHERENCE TO LIPID–LOWERING THERAPIES IN ACHIEVING LIPID TARGET: FINDINGS FROM REAL–WORLD ANALYSIS IN ITALY (2022) (0)
- Efficacy of zofenopril in combination with thiazide diuretics in patients with acute myocardial infarction: a pooled individual data analysis of four randomized, double-blind, controlled, prospective studies (2018) (0)
- Reclassification of cardiovascular risk in Europe: application of the updated Systematic COronary Risk Evaluation (SCORE) algorithm incorporating high-density lipoprotein levels (2012) (0)
- [52] STATIN USE IN BRISIGHELLA HEART STUDY POPULATION (2009) (0)
- [Intralymphocytic sodium: test to predict response to stress in borderline hypertension]. (1981) (0)
- Dual RAAS inhibition and cardiorenal disease: is enough really enough? (2020) (0)
- Synergistic Effects of Calcium Antagonists and Statins on Endothelial Function (2007) (0)
- The 2018 European guidelines : tailoring treatment to new hypertension goals (2019) (0)
- CARDIOPROTECTIVE ROLE OF ZOFENOPRIL IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: THE EXPERIENCE OF THE SMILE PROGRAM (2014) (0)
- Th-W51:2 The role of statins in blood pressure control (2006) (0)
- Selected Abstracts from the XXII National Congress of the Italian Society of Hypertension: 2005 September 27–30, Turin, Italy (2005) (0)
- 751 Role of non steroidal anti-inflammatory drugs in the instability of clinical picture of patients with heart failure and rheumatic diseases (2007) (0)
- Acknowledgement to Referees (2015) (0)
- The short-circuit evidence on lipid-lowering drugs use in pregnancy. (2023) (0)
- Systemic haemodynamic profile and labyrinthine disorders (2006) (0)
- PO20-625 EFFICACY OF SOLUBLE FIBER SUPPLEMENTATION IN CVD RISK MANAGEMENT OF PATIENTS AFFECTED BY METABOLIC SYNDROME: A 6-MONTHS, OPEN-LABEL, RCT (2007) (0)
- Abstract: P1292 A DIETARY EDUCATION PROGRAM INVOLVING THE GENERAL POPULATION BALANCES THE EFFECTS OF MENOPAUSE ON CARDIOVASCULAR RISK FACTORS AND METABOLIC SYNDROME INCIDENCE: DATA FROM THE BRISIGHELLA HEART STUDY (2009) (0)
- HOW WE CAN TRUST MEASURES OF BPV SINCE IT'S VALUE IS SO VARIABLE ITSELF? (2018) (0)
- Correction: Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension (2022) (0)
- QUANTIFICATION DAILY PHYSICAL ACTIVITY IN MIDDLE-AGE HYPERTENSIVE PATIENTS LIVING IN THE CITY OF BOLOGNA: PP.15.62 (2010) (0)
- Efficacy and tolerability of valsartan in cardiovascular disease (2009) (0)
- PSYCHOLOGICAL DISTRESS, PSYCHOSOMATIC SYNDROMES AND PSYCHOLOGICAL WELL-BEING IN MASKED HYPERTENSION (2021) (0)
- Sensorineural hearing loss in pregnancy: an alternative, simpler possible explanation (2011) (0)
- 1.6 Brisighella Heart Study (BHS): Hypertension and Lipidic Parameters (2008) (0)
- [Atherosclerosis regression and plaque stabilization: comparison of therapeutic targets]. (2009) (0)
- COST EFFECTIVENESS OF ZOFENOPRIL IN THE TREATMENT OF PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION AFTER ACUTE MYOCARDIAL INFARCTION: A POST-HOC ANALYSIS OF THE SMILE-4 STUDY (2014) (0)
- 28 PHYSICAL TRAINING MODULATION OF PROTHROMBOTIC AND MICROINFLAMMATORY PARAMETERS IN HYPERTENSIVE OVERWEIGHT PATIENTS (2008) (0)
- Letter by Borghi and Cicero Regarding Article, "Modifiable Risk Factors and Atrial Fibrillation". (2018) (0)
- 2.13 Prevalence of Metabolic Syndrome in a Population of Patients with Rheumatoid Arthritis (2007) (0)
This paper list is powered by the following services:
Other Resources About Claudio Borghi
What Schools Are Affiliated With Claudio Borghi?
Claudio Borghi is affiliated with the following schools:
